ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
1   
ATN 151 Version 5.2 
May  23, 2017  
Revised August  5, 201 9 
 
Work 2Prevent: Employment as HIV prevention for young men who have sex with men 
(YMSM) and young transgender women (YTW)  
 
 
A Study of the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)  
 
 
Sponsored by:  
The Eunice Kennedy Shriver  
National Institute of Child Health and Human Development (NICHD)  
 
 
with co -funding from:  
 
The National Institute on Drug Abuse (NIDA)  
 
The National Institute of Mental Health (NIMH)  
 
National Institute on Minority Health and Health Disparities (NIMHD)  
 
 
 
 
 
 
 
 
Protocol Chair:  Brandon Hill, Ph.D  
 
Protocol Vice -Chair:  Robert Garofalo, MD, MPH  
 
NICHD Health Scien tist Administrator:  Sonia S. Lee, Ph.D.  
 
[STUDY_ID_REMOVED]  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
2  TABLE OF CONTENTS  
STUDY MANAGEMENT  ................................ ................................ ................................ .............  6 
LIST O F ABBREVIATIONS AND DEFINITION OF TERMS  ................................ ...............  7 
STUDY ABSTRACT  ................................ ................................ ................................ ......................  9 
STUDY SCHEMA  ................................ ................................ ................................ ........................  11 
1.0 INTRODUCTION ................................ ................................ ................................ ........  12 
1.1  Background  ................................ ................................ ................................ ...............................  12 
1.2  Rationale  ................................ ................................ ................................ ................................ .... 13 
2.0 STUDY OBJECTIV ES ................................ ................................ ................................  13 
2.1  Primary Objective  ................................ ................................ ................................ ....................  13 
2.2  Secondary Objective  ................................ ................................ ................................ .................  13 
2.3  Tertiary Objective  ................................ ................................ ................................ ....................  13 
2.4  Study Hypotheses/Research Questions  ................................ ................................ ...................  14 
3.0 STUDY DESIGN  ................................ ................................ ................................ ..........  14 
3.1  Study Population  ................................ ................................ ................................ .......................  15 
3.2 Sample S ize ................................ ................................ ................................ ................................  15 
3.3 Outcome Measures  ................................ ................................ ................................ ...................  15 
3.4 Biological Specimens  ................................ ................................ ................................ ................  15 
4.0 SELE CTION AND ENROLLMENT  OF STUDY PARTICIPAN TS ....................  16 
4.1 Inclusion Criteria  ................................ ................................ ................................ ......................  16 
4.2 Exclus ion Criteria  ................................ ................................ ................................ .....................  17 
4.3 Recruitment and Screening  ................................ ................................ ................................ ..... 18 
4.4 Informed Consent  ................................ ................................ ................................ .....................  18 
4.5 Contact Information  ................................ ................................ ................................ .................  19 
4.6 Co-enrollment Guidelines  ................................ ................................ ................................ ........  19 
5.0 STUDY PROCEDURES  ................................ ................................ .............................  19 
5.1 Intervention Enrollment Procedures  ................................ ................................ ......................  21 
5.2 Intervention/Investigation Procedures  ................................ ................................ ...................  21 
6.0 EVALUATIONS AND MEAS URES  ................................ ................................ .........  22 
6.1 Pilot -Test Screening  ................................ ................................ ................................ ..................  23 
6.2 Base line/Enrollment  ................................ ................................ ................................ .................  23 
6.3 Workshop Intervention  ................................ ................................ ................................ ............  23 
6.4 Post-Intervention  ................................ ................................ ................................ ......................  24 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
3 6.5 Interven tion Follow -Up ................................ ................................ ................................ ............  24 
7.0 DATA COLLECTION AND SITE MONITORING  ................................ ................  24 
7.1 Development of Protocol and Case Report Forms  ................................ ................................  24 
7.2 Data Records  ................................ ................................ ................................ .............................  24 
7.3  Data Collection and Submission  ................................ ................................ ..............................  24 
7.4 Data Quality Assurance  ................................ ................................ ................................ ...........  25 
7.5 Role of Data Management  ................................ ................................ ................................ ........  25 
7.6 Study Site Monitoring and Record Availability  ................................ ................................ .... 25 
8.0 PARTICIPANT MANAGEME NT................................ ................................ .............  26 
8.1 Tracking Participants / Follow -up ................................ ................................ ..........................  26 
8.2 Study Visit Management  ................................ ................................ ................................ ..........  26 
8.3 Compensation  ................................ ................................ ................................ ............................  27 
8.4 Intervening on “Social Harms"  ................................ ................................ ...............................  27 
8.5 Criteria for Premature Discontinuation  ................................ ................................ .................  29 
9.0 MONITORING & REPORTI NG SAFETY EVENTS  ................................ ............  29 
9.1 Study Team Review  ................................ ................................ ................................ ..................  29 
9.2       Re portable Safety Events  ................................ ................................ ................................ ...... 30 
9.3 Safety Event Reporting Periods  ................................ ................................ ..............................  30 
10.0  STATISTICAL/ANALYTIC  CONSIDERATIONS  ................................ .................  31 
10.1  Study Design  ................................ ................................ ................................ ..............................  31 
10.2  Sample Size  and Power Estimates  ................................ ................................ ...........................  31 
10.3  Statistical Analysis Plan  ................................ ................................ ................................ ...........  31 
10.4  Missing, Unused and Spurious Data  ................................ ................................ .......................  32 
11.0  HUMAN SUBJECTS  ................................ ................................ ................................ ... 33 
11.1  Participant Confidentiality  ................................ ................................ ................................ ...... 33 
11.2  Certificate of Confidentiality  ................................ ................................ ................................ ... 33 
11.3  Risks and Benefits  ................................ ................................ ................................ .....................  34 
11.4  Institutional Review Board (IRB) Review and Informed Consent  ................................ ...... 34 
11.5  Waiver of the Requirement for Parental Permission for Special Circumstances ...............  35 
11.6  45 CFR Parts 160 and 164 Standards for Privacy of Individually Identifiable Health 
Information ("Privacy Rule" Pursuant to the Health Insurance Portability and 
Accountability Act - HIPAA)  ................................ ................................ ................................ ... 35 
11.7  Study Discontinuation  ................................ ................................ ................................ ..............  35 
12.0  PUBLICATION OF RESEA RCH FINDINGS  ................................ .........................  36 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
4 13.0  BIOHAZARD CONTAINMEN T ................................ ................................ ...............  36 
14.0  REFERENCES  ................................ ................................ ................................ .............  36 
APPENDIX I  ................................ ................................ ................................ ................................ . 39 
Schedule of Evaluations  ................................ ................................ ................................ .....................  39 
APPENDIX II  ................................ ................................ ................................ ...............................  40 
Phase I Documents  ................................ ................................ ................................ .............................  40 
Focus Group Guide  ................................ ................................ ................................ ............................  41 
Key Informant Employers Guide  ................................ ................................ ................................ ...... 43 
Informant YMSM and YTW Guide  ................................ ................................ ................................ . 45 
Screening Instrument  ................................ ................................ ................................ .........................  48 
APPENDIX III  ................................ ................................ ................................ ..............................  49 
Planned Enrollment Report – Pilot Test  ................................ ................................ ..........................  49 
APPENDIX IV  ................................ ................................ ................................ ..............................  50 
iFOUR Description  ................................ ................................ ................................ .............................  50 
APPENDIX V  ................................ ................................ ................................ ...............................  52 
Certificate of Confidentiality  ................................ ................................ ................................ .............  52 
 
 
 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
5 ATN PROTOCOL TEAM ROSTER  
 
Protocol Chair  
Brandon Hill   Ph.D.  
6030 S Ellis Ave  
Chicago, IL 60637  
Phone:  773.834.8509  
E-mail:  bhill2@bsd.uchicago.edu  
 Protocol Vice -Chair  
Robert Garofalo,  MD, MPH  
4711 N. Broadway  
Chicago IL 60640  
Phone:  312-227-6110  
E-mail:  rgarofalo@luriechildrens.org  
 
ATN CC Co -Investigator  
Lisa C. Strader  
UNC Dept. of Biostatistics  
Collaborative Studies Coordinating Center  
137 E. Franklin Street, Ste. 203  
Chapel Hill, NC 27514  
Phone: (919) 96 6-8333  
E-mail: lstrader @unc.edu  
 NICHD Health Scien tist Administrator  
Sonia S. Lee, Ph.D  
Eunice Kennedy Shriver National Institute of 
Child Health and Human Development 
(NICHD)  
6710B Rockledge Drive  
Bethesda, MD 20 817 
Phone: (301) 5 94-4783  
E-mail: leesonia@mail.nih.gov  
 
Protocol Manager  
Rachel Goolsby  
UNC Dept. of Biostatistics  
Collaborative Studies Coordinating Center  
137 E. Franklin Street, Ste. 203  
Chapel Hill, NC 27514  
Phone:  919 843 -0685  
Fax: 919 962 -3265  
E-mail:  rwgoolsby@email.unc.edu  
 University of Chicago Site Chair  
Darnell Motley Ph.D  
6030 S Ellis Ave  
Chicago, IL 60637  
Phone: 773-834-4862  
E-mail: dmotley @bsd.uchicago.edu  
 
 
Project Manager  Project Statistician  
Kris Rosentel, MPH  Micah McCumber   
6030 S Ellis Ave  UNC Dept. of Biostatistics  
Chicago, IL 60637  Collaborative Studies Coordinating Center  
Phone: 901 -878-9875  137 E. Franklin Street, Ste. 203  
 E-mail: micahmc@email.unc.edu  
  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
6 STUDY MANAGEMENT  
Before the recruitment and enrollment of participants, the participating study site must have the protocol 
and consent form approved by their local Insti tutional Review Boards (IRBs). In addition, study site must 
receive protocol registration approval from the ATN Coordinating  Center ( CC) by submitting a complete 
registration packet with the site’s IRB approved documents and a site registration form.  All original 
approved documents must be maintained at the clinical site . 
 
All queries for this protocol should be sent to the ATN (151) project team using the ATN Protocol Query 
and Notification System  (QNS)  accessible via the ATN website (https://sites.cscc.unc.edu/atn/ ). The 
appropriate team member will respond to queries generally within 48 business hours via the ATN Q NS. 
The Protocol Manager , with the help of other ATN CC personnel , Protocol Chair  and/or NICHD, if 
necessary, will answer  queries related to  general protocol implementation, eligibility  and CRF 
compl etion. The Protocol Chair or his/her designee will respond to study and participant management, 
exemptions and/or untoward  event queries. This study follows the ATN Policy for Guidance for Safety 
and Impact Reporting. Queries and replies will automatically be archi ved at the ATN CC. The CC will 
post those queries deemed relevant to all sites on the ATN 151 FAQ page , where they will be available 
for future reference.  
 
This study will use the Audio Computer -Assisted Self-Interview (ACASI) to collect study data.  All 
questions related to the ACASI should be directed to the ATN Help Desk at the ATN CC by calling the 
toll-free ATN ACASI helpline at 1  (866) 257 -7242  or by e mail (ATNhelp@un c.edu ). 
 
For protocol registration issues, contact the ATN Coordinating Center ATNhelp@unc.edu .   
 
 
 
 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
7 LIST OF ABBREVIATION S AND DEFINITION OF TERMS  
ACASI    Audio Computer Assisted Self Interview  
AEs                                Adverse Events  
AFC  AIDS Foundation Chicago  
AIDS    Acquired Immunodeficiency Syndrome  
ATN    Adolescent Medicine Trials Network for HIV/AIDS Interventions  
CAB  Community Advisory Board  
CDART   Carolina  Data Acquisition and Reporting Tool  
CDC  Centers for Disease Control and Prevention  
CFR  Code of Federal Regulations  
CGSHP   Lurie Children’s Hospital Center for Gender, Sexuality and HIV Prevention  
Ci3 Center for Interdisciplinary Inquiry & Innovation in Sexual and Reproductive Health  
CRF    Case Report F orm 
CT   Chlamydia   
DHHS    U.S. Department of Health and Human Services  
CC   ATN Coordinating  Center  
eCRF   Electronic Case Report Form  
GC   Gonorrhea  
GEE  Generalized Estimating Equations  
HBM  Health Belief Model  
HIPAA    Health Insurance Portability and Accountability Act  
HIV   Human Immunodeficiency Virus  
HRSA  Heath Resources and Services Administration  
IATA  International Air Transport Association  
ICH   International Conference on Harmonization  
iFOUR  Increase Individual Income and Independence Program  
IRB   Institutional Review Board  
LGBT  Lesbian Gay Bisexual Transgender  
MATEC  Midwest AIDS Training and Education  
MSM  Man who has sex with men 
NICHD    National Institute of Child Health and Development  
NIDA    National Institute on Drug Abuse  
NIH   National Institutes of Health  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
8 OHRP    Office of Human Research Protection  
OSHA  Occupational Safety and Health Administration  
PI   Principal Investigator  
PrEP   Pre-Exposure Prophylaxis  
QA Quality Assurance  
QNS    Query and Notification System  
RA Research Assistan t 
SE Model  Supported Employment  Model  
SAEs                              Serious Adverse Events  
SID   Study  Identification Numbe r 
SMC  Study Monitoring Committee  
SPSS  Statistical Package for the Social Sciences  
STI Sexually Transmitted Infections  
T1 Baseline study visit  
T2 Post-Intervention study visit  
T3 Month 8 follow -up visit  
UC University of Chicago  
UEs                                Untoward Events    
UNC  University of North Carolina  
YMSM  Young Men Who Have Sex with Men  
YTW  Young Transgender Women  
 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
9 STUDY ABSTRACT  
DESIGN:  Work2Prevent  will advance  the science by adapting, tailoring, and 
pilot-testing a novel social and structural-level HIV intervention 
for YMSM and YTW of color ages16 -24 aime d at increa sing 
economic stability (i.e., employment) through youth empowerment 
and asset development, and decreasing HIV risk behaviors (i.e., 
sex work) associated with social and economic marginalization. 
DURATION:  Pilot -testing will last approximately 22 months   
POPULATION:  All focus group, p ilot-test, and the majority of key informant 
interview study participants will be Black/African American and/or 
Hispanic/Latinos males and transgender women (those assigned 
male at birth), ages 16 -24 who identify as either: (1) a man who has 
sex with men (MSM) and/or gay or bisexual man; or (2) a 
transgender woman and/or transse xual male-to-female/transwoman. 
Additionally, key informant interview study pa rticipants will be any 
race/ethnicity and sex/gender, but will be identified as an employer 
and/or hiring manager of an LGBT-inclusive company.  
STUDY INTERVENTION:  Intervention will consist of a series of 4 workshops that promote job 
seeking self -efficacy and job readiness. These workshops will be 
adapted from the existing iFOUR curriculum, a job readiness 
program for transwomen developed by the Chicago House. The 
iFOUR curriculum will be adapted based on feedback from the 
CAB, focus groups, and key informant interviews.   
DATA COLLECTION:  Data will be collected through transcribed, digital audio -recorded 
interviews, ACASI, and eCRFs.  
PRIMARY OBJECTIVES:  Determine the essential components of a theoretically -driven and 
developmentally -appropriate e mployment intervention aimed at 
increasing job seeking self-efficacy and readiness among YMSM 
and YTW of color ages 16 -24. 
SECONDARY OBJECTIVES:  Review and adapt relevant intervention components from the 
existing evidence -based employment program for HIV -positive 
adults (iFOUR) to YMSM and YTW of color.   
TERTIARY OBJECTIVES:  Refine and pilot -test the employment intervention .  
Refine and Pilot -test the intervention in community -based settings.  
RISK/BENEFIT CATEGORY:  Minimal  
MONITORING:  Routine team monitoring of any adverse impact of the study will 
rely on the ATN Protocol Query & Notification System, a real -time, 
web-based interactive reporting system. Sites will also record and 
enter in the study database, all untoward events  associate d with 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
10 study participation, which will be reviewed on the protocol team’s 
implementation monitoring calls . 
  
  
  
  
  
  
  
  
  
  
  
 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
Page 11 of 57 
 STUDY SCHEMA  
 
STUDY VISITS  
 Community Pilot -Test Enrollment
n=up to 40Intervention Pilot -Test Enrollment
n=up to 70Intervention Pre -Test Enrollment
n=up to 5Community advisory board (CAB) 
n=up to 12Focus groups and Key Informants
Focus Groups: n=up 
to 80Key Informants:           
n=up to 64
Baseline 
(T1)Workshop classes
Phase 2: 0 -12 weeks of T1
Phase 3: 0 -4 weeks of BLPost -Intervention 
(T2)
Phase 2 & 3: 0 -2 weeks 
after last classFollow -Up (T3)
Phase 2: 8 months ( ±4 wks) 
after last class 
Phase 3: 3 months ( ±2 wks) 
after last class
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
Page 12 of 57 
 1.0 INTRODUCTION  
1.1  Background  
Young men who have sex with men (YMSM) and young transgender women (YTW) face enormous 
disparities. In particular, HIV  risk and infection among YMSM  and Y TW remains a significant public 
health problem. Furthermore, YMSM  and YTW  experience  social  and economic  marginalization, which 
leads to high rates of unempl oyment,  sex work, drug use, homelessness,  and HIV risk. Sex in exchange  for 
money, drugs,  and/or food among  YMSM  and YTW  of color  is a significant  public  health  problem.  
Adolescent  sex work places  YMSM  and YTW  at increased  risk for STIs, HIV,  poor mental  health  
outcomes,  and subst ance abuse. Interventions  that trace  and disrupt  the pathways between social  and 
structural  determinants  of HIV infection  are needed. Structural -level  interventions  foster agency  to allow  
individuals  to act in their own and  their communities’  best interes ts, and have  been  positi vely associa ted 
with the uptake  of behavioral  and biomedical  technologi es, as well as the promotion  of health -enabling  
environments. To  date, few struct ural interventions  targeti ng adolescent  sexual  and gender  minorities  
exist,  and we know  of no studi es that have  explicitly  examined  the role  of employment  on HIV risk and 
prevention  for YMSM  and YTW.  Employment  as prevention  has the potential  to be a scala ble intervention  
that can be deployed  among  at-risk YMSM  and YTW.  
In the US,  YMSM  and YTW, experience  high rates  of HIV  infection  (CDC, 2012, 2013; Herbst et al., 
2008) . In 2010, YMSM,  including  YTW, age  13-24 rep resented 19% of all new HIV infections, and 72% 
of infections among adolescents (CDC, 2012) . However, such disparities  cannot  be attributed  to 
individual -level  risk alone,  but are situated  within larger  social and structural  contexts  that proximate  
YMSM  and YTW  of color  to increased  HIV expos ure (Baral et al., 2013; Bauer, Travers, Scanlon, & 
Coleman, 2012; Brennan et al., 2012; Garofalo, Osmer, Sullivan, Doll, & Harper, 2006; IOM, 2011; 
Operario & Nemoto, 2010) . Despite advancem ents in LGBT  rights,  LGBT  people  face persistent  stigma,  
discrimination,  and victimization  in school,  the workpl ace, housing,  and health  care (Melendez et al., 
2006; Santos et al., 2014) .  Such  inequities  are met with limited  legal protectio ns as few state laws 
speci fically  protect  LBGT  people. As a result, a fair majority  of YMSM  and YTW  of color  live in poverty, 
experiencing  high rates  of homelessness,  unemploy ment, and limited  access  to health and HIV 
services (Bradford, Reisner, Honnold, & Xavier, 2013; Gayles, Kuhns, Kwon, Mustanski, & Garofalo, 
2016; Meyer, 2003; Millett et al., 2012; Santos et al., 2014; Sevelius, Patouhas, Keatley, & Johnson, 
2014) . 
Faced  with few economic  options  and protectio ns, YMSM  and YTW  may migrate  to non-tradition al 
economies or  “street  careers”  as a means  of survival.  In a study conducted  by Adolescent  Medicine  Trials  
Network  for HIV/AIDS  Interventions  (ATN)  members in Los Angeles  (Belzer)  and Chicago  (Garofalo)  
[Co-I for this proposal],  76% of 151 YTW  ages 15-24 reported  engaging  in sex work,  with 35% in the past 
3-months (Auerbach, Parkhurst, & Caceres, 2011; Xavier, Bobbin, Singer, & Budd, 2005) . Among  HIV-
positive  YTW,  23% were  involved  in sex work —underscori ng the link between  adolescent  sex work  and 
HIV (Xavier et al., 2005) . In a large study  of YMSM  of color  (n=3,316,  median  age 19), roughly  12% 
reported  engaging in  sex work  (past  6-months)  (Melendez & Pinto, 2007) . Sex work  and HIV risk are 
further  complicated  by drug and alcohol abuse  (Gayles et al., 2016) .  Scala ble, low-cost, but potentially 
high impact, structural-level interventions that trace and disrupt the pathways between social and 
economic marginalization and adolescent HIV infection are sorely needed (Clements -Nolle, Marx, & 
Katz, 2006; Kammerer, Mason, Connors, & Durkee, 2001; Lomabrdi, Wilchins, Priesing, & Malouf, 
2002) . Structural interventions, such as comprehensive sex education, universal condom access, clean 
syringe exchange, and increas ed healthcare coverage have significantly reduced the incidence of HIV 
(Bockting, Miner, Swinburne Romine, Hamilton, & Coleman, 2013; Bradford et al., 2013; Clements -
Nolle et al., 2006; Durso, Kastanis, Wilson, & Meyer, 2013; Grant et al., 2011; Kammerer et al., 2001; 
Lomabrdi et al., 2002; Reisner, Bailey, & Sevelius, 2014) . The objective of the proposed study is to  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
13 target economic stability (i.e., employment) as a structural -level intervention for preventing adolescent 
HIV. The  proposed  study will adapt  and pilot-test an effec tive theoreticall y-driven,  employment  program  
for HIV-positive  adults  (iFOUR ) (A Broken Bargain for LGBT Workers of Color , 2013; Dyer et al., 
2013; Fletcher, Kisler, & Reback, 2014; Kipke, Weiss, & Wong, 2007; Sifra Quintana, Roshenthan, & 
Krehely, 2010; Wilson et al., 2009) to the needs  of at-risk YMSM and  YTW  of color,  ages 16-24. This 
proposal  is responsive  to the NIH HIV/AIDS  high priority  topic  by developing,  testing,  and implementing  
a new strategy  to improve  HIV prevention.   
1.2  Rationale  
The goal of this project is to adapt, tailor, and pilot-test a novel social and stru ctural-level HIV 
interventi on for YMSM  and YTW  of color aimed at  increas ing economic stability (i.e., employm ent) 
through youth empowerm ent and asset development, and decreasing HIV risk behaviors (i.e., sex work) 
associated with social and economic margin alization. 
The specific aims of this project are to:  
1. Determine  the essential  components  of a theoretical ly-driven and developmental ly-appropriate 
empl oyment intervention  aimed  at increasing  job self-effica cy and readiness  among  YMSM  and 
YTW  of color  ages 16-24.  
2. Review  and adapt relevant  intervention  components  from  the existing  evidence -based empl oyment 
program  for HIV-positive adults  (iFOUR)  to YMSM  and YTW  of color.   
3. Refine  and pilot-test the empl oyment  intervention.  
4. Refine and p ilot-test the empl oyment  interventio n in community -based settings  
2.0 STUDY OBJECTIVES  
2.1  Primary Objective  
The primary objective is to d etermine  the essential  components  of a theoretical ly-driven and 
developmental ly-appropriate empl oyment intervention  aimed  at increasing  job seeking  self-effica cy and 
readiness  among  YMSM  and YTW  of color  ages 16-24. Up to 10 focus  groups with YMSM  and YTW  of 
color  who are currently  empl oyed or unemployed  but seeking  employme nt will inform  the adapta tion of 
the intervention.  Key informant  interviews with  YMSM  of color,  YTW of color,  and LGBT -inclusive  
employers  will address interve ntion content.  
2.2  Secondary Objective  
The secondary objective is  to review  and adapt relevant  intervention  components  from  the existing  
evidence -based empl oyment program  for HIV-positive adults  (iFOUR)  to YMSM  and YTW  of color.  The 
study will assemble  a community  advisory  board  (CAB)  of YMSM  and YTW of color,  youth -serving  
vocational  specialists, employment  training  and placement  experts,  and sexual  health  educators  to advise  
the investigative  team  on the  translation  of qualit ative findings  into curric ulum adaptations.  
2.3  Tertiary Objective  
The tertiary objective is to r efine  and pilot-test the empl oyment  intervention.  All qualitative  findings  will 
be incorporated into a protoc ol with the iterative  feedback  of the CAB. Next,  we will pre -test the Baseline  
visit, workshop sessions, and Post-Intervention  visit with a sample of up to 5 participants. We will pilot-test 
the entire intervention  among  up to 70 at-risk YMSM  of color  and YTW  of color  and then in community -
based settings with up to 40 at -risk YMSM of color and YTW of color in a single -arm pre/post  trial, 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
14 assessing  feasibility and acceptability . Study  outcomes  inclu de: (1) job seeking  self-efficacy  and readiness;  
(2) employment; (3) HIV risk behaviors;  and (4) STI and HIV infections .  
2.4  Study Hypotheses/Research Questions   
We hypoth esize that this intervention  will be both feasible  and acceptable  to the target  populations  and 
that the intervention  will incre ase job self-efficacy and readiness,  as well as decrease HIV risk behavior.  
This study  will lead  to a final intervention  manual  to be tested  in an R01-type,  large  multi -site trial across  
the ATN study  sites.  
3.0 STUDY DESIGN  
All research activities except for the community -based pilot will occur at the University of Chicago 
(UC), Center  for Interdisci plinary Inquiry  and Innovation  in Sexual  and Reproductive  Health  (Ci3). Ci3 is 
a foundation  and federally  funded  research  center focused  on advancing  adolesc ent sexual and 
reproductive  health  and rights  through innovative research  methodologies,  intervention  strategies,  and 
novel  solutions  to broad social  problems.  Ci3 has a dedicated  research  team  skilled  in cross-discipli nary 
collaboration  focus ed on adolescent  health  along with  a broad network of commu nity partners working 
with LGB T adolescents, and environments that will support the successful development, 
implementation, and evaluation of the project . 
Community -based pilot -testing will be conducted by study staff in the community at the following 
organizations:  
 The Village (Chicago Center of HIV Elimination, University of Chicago)  
 Task Force Prevention and Community Services  
 Ann & Robert H. Lurie Children’s Hospital of Chicago   
Each community setting has a private area for the confidential conduct of the study, including study visits 
and workshop sessions.    
Conceptual  Model:  Our conceptual model (Figure 1 ) draws on the existing iFOUR theoretical 
framework that  operationalizes the Health Belief Model ( HBM ) and the Supported Employment  Model 
(SE) to hypothesize the potential relationship between adolescent employment and HIV risk. W e 
propose that employment, and subsequent economic connection and stability, serves as a structural -level 
intervention for adolescent HIV. Based on prior research, we hypothesize that the adapted and tailored 
iFOUR intervention will facilitate increased jo b seeking  self-efficacy and job readiness [Path A]  and 
ultimately increase employment placement and maintenance [Path B]. Further, we hypothesize that 
establishing economic stability will decrease engagement in HIV risk behaviors and increase HIV 
preventio n and care [Path C], and  decrease involvement with known social determinants of HIV (e.g., 
sex work, drug abuse) [Path D], that are directly linked to HIV transmission and acquisition [Paths E & 
F] among YMSM and YTW of color.  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
15  
3.1  Study Population  
All focus group, p ilot-test, and the majority of key informant interview study participants will be 
Black/African American and/or Hispanic/Latinos males and transgender women (those assigned male at 
birth), ages 16 -24 who identify as either: (1) a man who has sex with men (MSM) and/or gay or bisexual 
man or (2) transgender woman and/or transse xual male-to-female/transwoman. Additionally, key 
informant s and study pa rticipants will be any race/ethnicity and sex/gender, but will be identified as an 
employer and/or hiring manager of an LGBT-inclusive company. Targeted Planned  Enrollment tables 
contain the detailed breakdown for each  recruitment and enrollment ac tivity (Appendix I II). 
3.2 Sample Size  
Focus  Groups:   We will recruit  up to 80 YMSM  and YTW of color,  ages 16-24, to participate  in one of up 
to 10  focus groups . 
Key Informant  Intervie ws: We will recruit  up to 64 key informant  YMSM  (n=up to 12 ), YTW  (n=up to 
12), and LGBT -inclusive  employers  (n=up to 40) to particip ate in key informant  interviews.  
Community Advisory Board : Up to 12-mem ber CAB  of YMSM,  YTW,  youth -serving employment and 
vocational specialist, LGBT employment training and placement experts, and sexual health educators.  
Intervention Pre-Test: We will pre-test the adapted  employment  intervention  with a small  sample  of up to 
5 YMSM  of color and YTW  of color.  
Intervention Pilot-Test: We will pilot -test the adapted  employment  intervention  with a diverse sample  of 
up to 7 0 YMSM  of color and YTW  of color . 
Community Pilot -Test: We will test the intervention with a sample of up to 40 YMSM of color and 
YTW of color in community -based settings . 
3.3 Outcome Measures  
Study outcomes include: (1) job seeking  self-efficacy and readiness; (2) employment; (3) HIV risk 
behaviors; and (4) STI and HIV infections.  
3.4 Biological Specimens  
Project staff members who have completed mandatory training will conduct  HIV/STI testing. Study 
participants will be screened  for drug use  and STIs such as chlamydia, gonorrhea, syphilis, and HIV 

ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
16 infection at the baseline and follow -up visits. Clinical spec imens may include 15-20 mL first-catch 
urine, anal s wab (GC,CT), oral/laryngeal swab ,  and finger stick. Participants with reactive STI or HIV 
tests will be referred to affiliated clinics at each  site for evaluation and treatment. All participant referral 
clinics will be comprehens ive and follow the Ryan White HIV/AIDS Programming instruction as 
developed  by the HRSA HIV/AIDS Bureau. Senior Investigators are practicing ph ysicians at study 
referral sites with experience in YMSM and YTW health, and  will provide any subse quent mental hea lth, 
medical case management, and  psychosoc ial suppo rt service referrals as needed  for pa rticipants. 
Following the protocols of our previous studies involving HIV testing, HIV-positive participants at 
follow-up will not receive HIV testing if they produce  docu mentation of a previous diagnosis (e.g., 
medications, lab report). In addition, phase 3 participants with a known HIV positive status at the time 
of consent will not receive HIV testing at baseline or follow -up.  
4.0 SELECTION AND ENROLL MENT OF STUDY PARTICIPANT S 
4.1 Inclusion Criteria  
4.1.1  Focus  Group Inclusion Criteri a  
Must meet the following six criteria:  
1. Male or assigned male at birth (YTW)  
2. Identify as a man who has sex  with men  (YMSM) and/or gay bisexual man  or tran sgender 
woman /trans woman  
3. Identify as African American/Black, Hispanic/Latino, and/or a racial/ethnic minority or pe rson of 
color  
4. 16-24 years o ld  
5. English-speaking (primary)  
6. One of the following:  
a. Currently employed  
b. Unemployed but seeking employment 
4.1.2  Key Informant Interviews Inclusion Criteria for YMSM and YTW  
Must meet the following six criteria:  
1. Male or ass igned male at birth (YTW) [YMSM/YTW only] 
2. Identify as a man who has sex with men (YMSM) and/or gay bisexual man or transgender 
woman/transwoman  
3. Identify as African American/Black, Hispanic/Latino, and/or as a racial/ethnic minority or 
person of color 
4. 16-24 years old  
5. English-speaking (primary) 
6. One of the following:  
a. Currently employed  
b. Unemployed but seeking employment 
 4.1.3  Key Informant Interviews Inclusion Criteria for LGBT -Inclusive Employers  
Must meet the following four criteria:  
1. Employer s and/or manager s at LGBT -inclusive compan ies which:  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
17 a. Scored 80 % or higher on the Human Rights Campaign,  Corporate Equality Index  
2015 -2016  or 
b. Is a company currently listed as an Out  & Equal, LGBT CareerLink employer  or 
c. Is a non -profit organization with an LGBT -focused mission or 
d. Is an LGBT -owned small business (<200 employees)  or 
e. Is a company or organization participating in an LGBTQ job fair  
2. Located in the Chicago area  
3. English-speaking  
4. 18 years or older 
4.1.4  Phase 2 Intervention Pre Test & Pilot -Test Inclusion Criteria  
Must meet the following eight criteria:  
1. Male or assigned male at birth (YTW)  
2. Identifies as a man who has sex with men (YMSM) and/or gay bisexual man or transgender 
woman/transwoman  
3. Identifies as African American/Black, Hispanic/Latino, and/or as a racial/ethnic minority or 
person of color 
4. 16-24 years old 
5. English-speaking (primary)  
6. HIV negative or of unknown status  
7. Currently unemployed but se eking employment or employed only part -time 35 hrs or less on 
avg/wk)   
8. Able to attend a 4-session employment program 
4.1.5  Phase 3 Community Pilot  Inclusion Criteria  
Must meet the following eight  criteria:  
1. Male or assigned male at birth (YTW)  
2. Identifies as a man who has sex with men (YMSM) and/or gay bisexual man or transgender 
woman/transwoman  
3. Identifies as African American/Black, Hispanic/Latino, and/or as a racial/ethnic minority or 
person of color 
4. 16-24 years old 
5. English-speaking (primary)  
6. Currently unemployed but se eking employment or employed only part-time 35 hrs or less on 
avg/wk)   
7. Able to attend a 4-session employment program 
8. Did not participate in Phase 2 pilot  
 
4.2 Exclusion Criteria  
4.2.1  Focus Groups  
Must not meet any of the following:  
1. Individuals identify as non -Hispanic White  
2. Individuals not assigned male at birth  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
18 4.2.2  Community Advisory Board Exclusion criteria:  
Must not meet any of the following:  
1. Under age 18  
2. White, Asian, Native American, and any other ethnic group not Black or Latino  
There are n o exclusions regarding sex/gender for the Community Advisory Board . 
4.2.3  Intervention Pilot -Test Exclusion Criteria  
Must not meet any of the following:  
1. Individuals identify as non -Hispanic White  
2. Individuals not assigned male at birth  
3. Phase 2 only: Individuals with a known HIV positive -status at baseline  
4.3 Recruitment and Screening  
Recru itment. Study participants will be recruited by research assistants (RAs) and study recruiters who 
are also  members of the target popu lation. For the CAB, focus groups, and key informant interviews , 
participants will be recruited by the RAs through pre -existing network connections, including the Chicago 
Center for HIV Elimination and snowball sampling.  Planned recruitment strategies for LGBT -Inclusive 
Employers also include attending LGBTQ job fairs and emailing LGBTQ non -profits, LGBTQ -owned 
small businesses, and employers in the Human Rights Campaign Corporate Equality Index or Out & 
Equal, LGBT CareerLink lists.  
For the pilot in tervention s, participants will be recruited actively by RAs and study recruiters in primary 
and community clinics serving YMSM and YTW of color, and local gathering places and events for 
YMSM and YTW such as  night clubs, House & Ball events, and other p ublic places that serve the LGBT 
community (e.g., LGBT cen ters). Additionally, participants will be asked to refer friends or acquaintances  
that may be eligible. Passive recruitment will include posting study flyers and posters, and describing the 
study on Facebo ok and other social media websites.   
4.4 Informed Consent  
Consent  Proces s. Eligible study participants will be taken through the informed consent p rocess in a 
private room.  RAs will review the consent process to make a formal asse ssment of the participant’s 
decisional capac ity to conse nt prior to signing using a 2-step process. First, the RA will determine if the 
person unde rstands the study goals by asking “Can you tell me what this study is abou t?” In step 2, 
potential participants will be asked questions designed to assess  their capacity to unde rstand, appreciate, 
reason  with, and express a choice about participation in our spec ific protocol. Participants  are asked to: (1) 
name things they will be expected to do during the study; (2) explain what they would do if they no longer 
wished to participate in the study; (3) explain what they would do if they experienced  distress du ring the 
study; and (4) identify potential risks for pa rticipating in the study. Responde nts will be enrolled only if 
they are able to provide clear and correct answers to each of these items. If study staff feels there is a 
question about the need  for a more formal asses sment of the decisional c apacity of a potential pa rticipant, 
they will con tact the Project Lead or other senior staff. Additionally, study staff will inform the person 
that the research study is voluntary and their dec ision whether or not to participate will not impact their 
relationsh ip with the research site or any subsequent participa tion in research studies or car e provided by the 
study site.  If they agree to participate, they will be immediately enrolled in the study (Appendix VI).  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
19 Paren tal Consen t. We will not require parental consent for study enrollment and participation. Parental 
consent may decrease participation rates becau se some youth will fear that they may be “outed” as a result 
of participation. Disclosure of sexual o rientation or gender  identity may place participating youth at risk 
for parental harassment, abuse or expulsion from the home. The nature and scope  of the proposed  research 
do not  pose more than “minimal risk” to participants (45 CFR Part 46.102): “the probab ility and 
magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than 
those ordinarily encoun tered in daily life or during the performance of routine physical or  psychological 
examinations or tests.” Study measures are standard in this popu lation, as are waivers of parental 
permission for survey and interview studies. Additionally, risk beha vior asses sments will be based  on the 
National Youth Risk Behavior Survey 2015,  which has been  administered to youth in 9th to 12th grade. 
HIV/STI testing is also common (and encou raged) a mong this group, and  does not require parental 
permission or notification in the state of Illinois. 
To compensate for waiver of parental consent p articipants receive a formal individual assess ment of 
capac ity to conse nt (above) to ensure their understanding of study goals, proced ures, and risks from 
disclosure of sens itive information (see Consent Process). Consistent with national po licy 
recommenda tions from the Society for Adolescent Medicine, requiring parental pe rmission for the 
proposed  study would have a number of poss ible negative effects, including: (1) reduc ing the validity of 
the findings by effectively eliminating potential participants unwilling to share permission forms with 
their parents/guardians; (2) increasing risk to some youth whose parents have a negative response  to the 
material in the permission forms that would (correctly) suggest their child has a minority or alternative 
gender identity; and (3) add ing little in the way of actual su bject protection, given the minimal risk of 
study participation.  
4.5 Contact Information  
Once consented, study staff will complete a Contact Information Form with the participant. Participants 
will be asked to provide a working phone number or valid email address through which they can be 
reached , and if messages can be left  at or texted to the numbers provided. Study staff will not leave  or 
send messages unless expressly permitted to do so by the. If permission is given to leave phone messages, 
site staff will assure participants that any messages left with a family member or friend will only ask the 
participant to contact study staff and will not include any protected health inform ation or information 
related to study participation.  
The Contact Information Form will not contain any study data and will be maintained under double locks 
at the study site, separate from all study records, with access limited to designated site research personnel.  
4.6 Co-enrollment Guidelines  
Studies that open after this protocol is implemented can be considered for co -enrollment either by 
requesting a blanket, one -time approval from the protocol team or by requesting case -by-case permission 
for co -enroll ment in writing from the protocol chair .  
5.0 STUDY PROCEDURES  
Aim 1: Determine the essential  components  of a theoreticall y-driven and developmentall y-
appropriat e empl oyment intervention  aimed  at increasing  job seeking  self-effica cy and readiness  
among  YMSM  and YTW  of color  ages 16-24. Two formative  assessment  strategies  will be used to 
determine  the essenti al components  of the employment  intervention:  (1) focus  groups  and (2) key 
informant  interv iews (Aim  1). First,  focus groups  be conducted  with current ly empl oyed and 
unemployed  (but seeking  employment)  YMSM  and YTW.  The goal of the  focus  groups  will be to 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
20 explore  and identify  the following:  perceived  barriers  to employment,  beliefs  in the benefit  of 
employment,  and career  counseling  needs of YMSM  and YTW. Additio nally, key components, 
including  potential  models  of the adapted iFOUR  employment  curriculum  will be shared and discussed 
with participan ts in order  to gauge  relevance  and potential  modif ications  for the target  population.  
Next,  we will conduct  key informant  interviews  with YMSM,  YTW,  and LGBT -inclusive  employers.  
The goal of this phase  of formative  research  will be to hone  and identif y key areas  related  to barrie rs 
and facilitators to hiring  and retainin g YMSM and YTW : YMS M and YTW caree r readiness,  
identifying  an inclusive employer,  and post- placement  support  necessary  to retain  YMSM  and YTW  
(Appendix II example  interview  guide).  
Focus  Groups:   Recruitmen t and Enrol lment.  We will recruit  up to 80 YMSM  and YTW of color,  ages 16-
24, to participate  in one of up to 10 focus groups  . 
Key Informant  Intervie ws: Recruitment  and Enrollment.  We will recruit  up to 64 key informant  YMSM  
(up to 12 ), YTW  (up to 12 ), and LGBT -inclusive  employers  (up to 40) to particip ate in key informant  
interviews.  Over 35 m ajor corpora te employers  in Chicago  have  a Corporate  Equality  Index  of 100%  (e.g.,  
Groupon,  Inc., McDonalds  Corp.,  etc) (HRC, 2015) . 
 
Aim 2: Review  and adapt  relevant  intervention  components  from  the existing  evidence -based 
empl oyment program  for HIV -positive  adults  (iFOUR)  to YMSM  and YTW  of color.  
Convene  a Community  Advisory  Board  (CAB).  Up to a 12-mem ber CAB  of YMSM,  YTW,  youth -
serving employment  and vocational  speci alists, LGBT  emplo yment  training  and placement  experts,  and 
sexual  health educators  will be led by Dr. Hill and the investigative  team.  Members  of the  CAB  will 
meet  no less than 20 times  over the course  of the project  to review  and interpret  qualitative  findings  into 
distinct  curriculum adaptations.  The CAB  will be instru mental  in providing  information  on curriculum  
content, appropriateness, cultural  sensitivity  and specificity,  study metho dology,  and best methods  for 
enhancing  participa tion, as well providing  ongoing  feedback  and interpretati on of data.  The CAB  will 
ensure  that the adaptati ons reflect  YMSM’s  and YTW’s  experience  and employment  needs  (Aim  2).  
Aim 3: Refine , pre-test, and pilot -test the employment  intervention.  In order  to achieve Aim 3, we 
will incorporate  all qualita tive findings  and refine  the final interv ention  curric ulum modul es using  
additional feedback  from the CAB.  In addition, the CAB will assist with Phase 2 by pre-testing and 
providing feedback on Phase 2 data collection instruments.  
The adapted  employment  intervention will first be pre-tested (Baseline , workshop s, Post-intervention ) with 
an initial sample of up to 5 participants in order to  test the implementation of assessments and workshop 
activities. Refinement to workshop activities will be considered if activities do not fit within the sessi on 
time-period or participants do not understand or comprehend the activity.    
Next, the intervention pilot-test of the final adapted  employment  intervention  will be completed with a 
diverse sample  of up to 70 YMSM  and YTW,  ages 16-24, in a single-arm longitudinal  pre/post  study of  
the employment  intervention  to evaluate  feasibil ity, acceptability,  program  satisf action, and preliminary 
efficacy  using assessments  at Baseline  (T1),  Post-Intervention  (T2),  and 8 Months  Follow -Up (T3).   
Aim 4: Refine  and pilot-test the intervention in community -based setting s. In order  to achieve Aim 4, we 
will refine  the procedures and intervention so that it may be conducted within community -based settings  
in order to  further test the implementation of assessments and workshop activities  in Phase 3 .  
The adapted  employment  intervention  will be completed with a diverse sample  of 40 YMSM  and YTW,  
ages 16-24, in a single-arm longitudinal  pre/post  study of  the employment  intervention  to evaluate  
feasibil ity, acceptability,  program  satisf action, and preliminary efficacy  using assessments  at Baseline  
(T1),  Post-Intervention  (T2),  and 3 Months  Follow -Up  (T3).  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
21  5.1 Intervention Enrollment Procedures  
An ATN Study  Identification number ( SID) will be assigned by the site staff in consecutive order from 
the Carolina Data Acquisition and Reporting Tool ( CDART ).  
5.2 Intervention/Investigation Procedures  
Up to 7 0 participants  will be enrolled for the intervention  pilot part of phase 2  and up to 40 participants 
for phase 3 . Participants will complete a 4 session  workshop. Workshops will be in groups of 6 -12. These 
workshops will be based on the pre-existing iFOUR  program  (description below)  with modifications 
based on CAB, fo cus group, pre-test, and int erview er feedback.  
iFOUR  
The Increase Individual Income and Independence program (iFOUR) is an employment program that was 
developed over ten years ago to target the employment needs of HIV - positive people. The program was 
based on the Supported Employment framework that was developed to help connect people with a range 
of disabilities (physical and cognitive) to employment because of the benefits of employment, both 
monetary and non -monetary. Thus, researchers at the University of Illin ois-Chicago collaborated with 
Chicago House, a housing and support organization for HIV - positive individuals, to develop a Supported 
Employment program for HIV - positive individuals. Like Supported Employment, iFOUR provides a 
variety of supports to aid i n participants' job success, such as job training referrals, client -tailored job 
placement, post -employment assistance, and benefits planning. The program includes regular interviews 
to evaluate program outcomes, such as medication adherence, use of drugs and alcohol, and assessments 
of physical and mental health. Since 2005, the iFOUR program has been refined to better tailor to the 
needs of HIV - positive individuals, including the addition of one -on-one work with a career specialist. 
These specialists ass ess job readiness and are trained in the impact of HIV/AIDS on employment, so as to 
best assist participants with their career aspirations. They also assist with linking participants to additional 
educational resources and provide support with interview pr eparation and development of resumes and 
cover letters. iFOUR also includes a four -week training workshop that is tailored to the needs of HIV -
positive participants, dealing with questions such as workplace discrimination, benefits maintenance, and 
the rel ationship of health beliefs and work. The workshop also covers confidence and communication 
skills, while highlighting the non -monetary benefits of employment. The iFOUR program has had 
positive outcomes for participants, documented in several studies (App endix IV). The goal of the current 
study is to tailor then pilot test the iFOUR program for indiv iduals who are HIV -negative but at high -risk 
for acquiring HIV.   
5.2.3 Research Staff Training  
Prior to engaging in any study specific activities, staff must  complete study trainings as outlined below:  
 GCP training  
 Human Subjects Protection training  
 W2P Workshop Facilitator Training : Members of the research team who facilitate workshop 
sessions will be trained by staff who have run the iFOUR program. This training includes an 
overview of how iF OUR  was implemented, challenges in implementation, and best practices for 
ensuring the utility of career readiness training.  
 Title IX  Training : All staff will complete  annual Title IX training in the prevention of sexual 
assault and sexual misconduct  via “Intersections: Preventing Harassment and Sexual Violence”  
 Suspected Child Abuse Reporting  Training : All staff will review guidelines related to their status 
as mandated reporters of suspected child abuse and neglect  if applicable by state law . 
Additionally, staff may opt  to complete the web-based training “Recognizing and Reporting 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
22 Child Abuse: Training for Mandated Reporters,” which defines when mandated reporters must 
contact Child Support Services if abuse or negle ct is suspected.  
 HIV Testing Training : Staff engaged in the collection of biological samples will complete  a 4 
hour specialized training on HIV client -centered counseling techniques , HIV prevention 
strategies , and other sensitive issues through the Midwest AIDS Training and Education Center . 
 Ready Set PrEP! Training : All staff will complete training regarding HIV prevention and PrEP 
access through the AIDS Foundation of Chicago’s (AFC) “Ready Set PrEP!” This tr aining 
focuses on how antiretroviral medication can be used for prevention of HIV transmission and 
how social determinants of health impact PrEP access.  
5.2.4 Intervention Monitoring /Quality Control  
Research staff running the workshops will complete fidel ity assessment s during administration of  each 
workshop class to help ensure and evaluate homogeneity across workshop groups.  In addition, workshop 
staff will conduct a debriefing session after the administration of each workshop class in order to note any 
issues or observations.   
6.0 EVALUATIONS AND MEAS URES   
The study procedures will unfold in three  phases, outlined below.  
Phase 1  
Focus groups and key informant interviews will be conducted.  Focus group participants will be asked to 
discuss perceived barriers to employment, beliefs in the benefits of employment , and career counseling 
needs of YMSM and YTW of color. Participants will also be asked to review key components of models 
of the adapted iFOUR employment curriculum to gauge relevance and potent ial modifications. Key 
informant interviews will be conducted and the topics covered in will be similar to the focus groups, 
while allowing for more in -depth investigation of individual experiences.  
Phase 2  
Based on the data collected during phase 1, we wi ll develop the adapted employment intervention  and 
complete an initial pre -test consisting of the Baseline visit , workshops, and Post-Intervention visits . We 
will then pilot the intervention with p articipants in a single -arm longitudinal pre -/post -study. A t Baseline , 
participants will complete a 30-60 minute audio -computer assisted self -interview (ACASI) survey covering  
sociodemographics, employment variables, HIV risk behavior variables, and potential modifying variables. 
Participants will also be asked fo r biological specimen  collection  for HIV/STIs screening and drug testing 
(such as  urine, oral /laryngeal  swab,  finger stick,  and anal swab).  Upon completion of the employment 
intervention  at Post-Intervention , participants will be asked to complete a second  30-45 minute ACASI 
survey regarding employment variables , HIV risk behavior variables , as well as the feasibility, acceptability 
and satisfaction of the program. After 8 months  post-intervention , participants will be asked to return to the 
study site to complete the Follow -Up visit and repeat  ACASI survey assessing sociodemographics, 
employment variables, HIV risk behavior variables, and potential modifying variables , as well as to provide 
repeat  biological specimens for HIV/STIs screening and drug testing.  
Phase 3  
We will further adapt study procedures and the employment intervention  so that it may be administered in  
community -based settings . All study procedures for Phase 3 are same as Phase 2 e xcept that the Follow -
Up visit is at 3 months follow -up, and the ACASI survey s are shorter in length at 20 -45 minutes each visit.      
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
23 6.1 Pilot -Test Screening  
Interested participants will be pre -screened for eligibility by the ATN 151 Screening Form, eit her via 
phone with study staff or online via a Qualtrics survey. Participants who are eligible at pre -screen will 
then be scheduled for their Baseline study visit.   
After informed consent, participants will be assigned a SID and then asked items from the ATN 151 
Eligibility Form to confirm that the participant meets study criteria.  
Table 1: Description of variables to be collected at each of t he three study time points.  
Study visits  Variables collected  
Baseline  Visit  (T1) Sociodemographics, employment variables, HIV 
risk behavior variables, and potential modifying 
variables  
HIV/STI screening and drug testing  
Workshop Intervention  Workshop fidelity and debriefing  
Post-Intervention Visit  (T2) Employment variables , variables assessing  
feasibility, acceptability, and satisfaction of 
intervention , and HIV risk behavior variables  
Follow -up Visit (T3) 
Phase 2: 8 Months  
Phase 3: 3 Months   Sociodemographics, employment variables, HIV 
risk behavior variables, and potential modifying 
variables  
HIV/STI screening and drug testing  
6.2 Baseline/ Enrollment  
After informed consent and eligibility  has been confirmed, p articipan ts will undergo  biologic al specimen  
collection  for HIV/STIs  screening and drug testing . Please note that for Phase 3, if a participant has a 
known positive HIV status they will not undergo HIV testing. Participants will be given  an iPad tablet and 
headphones  and asked to  complete  an ACASI  survey . The survey  inclu des items on : sociodemographics,  
employment  variables,  HIV risk beha vior variables , and potential modifying variables  including perceived 
transgender discrimination  scale, job  seeking  self-efficacy, managing interview,  resilience, employment 
and job search, integrated motivations, internal self -concept, goal internalization, perceived social 
support, drug use, alcohol use, sexual history, commercial sex work, homelessness, condom intentions, 
money  inventory, a nd PrEP awareness .    
6.3 Workshop Intervention  
After the Baseline visit  (T1), participants have up to 12 weeks to complete workshop classes  for Phase 2 and 
up to 4 weeks for Phase 3 , otherwise they will go on to complete the T2 and T3 visits.  Participant s who do not 
complete any workshop classes may still complete the T3 visi t. 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
24 6.4 Post-Intervention  
At the completion  of the workshop intervention , partic ipants have 0 -2 weeks to complete the post-
intervention  visit (T2). Participants  will complete  an ACASI  survey  assessing  the feasibility , 
acceptability , and satisfaction of the program , as well as emplo yment  variables  such as perceived 
discrimination, job self -efficacy, managing interviews, resilience, employment and job searching, motivations, 
goal setting, financial planning, and variables such as perceived social support, drug and alcohol use, sexual 
history, sex work, housing situation,  condom use, and HIV risk behaviors.   
6.5 Intervention Follow -Up  
For Phase 2 the follow -up visit (T3) is scheduled for 8 months post -intervention (±4 weeks), and for 
Phase 3 the follow -up visit is scheduled for 3 months post -intervention (±2 weeks) . At this visit, 
participants will repeat biological specimen  collection for HIV/STIs screening and drug use . If a 
participant already has a known positive HIV status they will not undergo HIV testing. Participants will 
repeat the ACASI  survey  with items on s ociodemographics, employment variables, HIV risk behavior 
variables, and potential modifying variables  such as perceived transgender discrimination  scale, job  
seeking  self-efficacy, managing interview,  resilience, employment and job search, integrated motivations, 
internal self -concept, goal internalization, perceived social support, drug use, alcohol use, sexual history, 
commercial sex work, homelessness, condom intentions, money  inventory, and PrEP awareness . 
7.0 DATA COLLECTION AND SITE MONITORING  
7.1 Development of Protocol and Case Report Forms  
The ATN CC, in collaboration with the Protocol Team, is responsible for the development of this 
protocol as well as the Case Report Forms (CRFs) and Audio Computer -Assisted Self Interview 
(ACASI ). All CRFs for this study will be available for download from the ATN study website.  
7.2 Data Records  
Participant -related study information will only be identified through a SID which will be on all participant 
CRFs  and ACASI response files. Participant n ames or other personally -identifying information will not 
be used on any study documents  except that contact information approved by the study participant will 
appear on study contact forms and reports, which wil l be securely maintained by both the site and the CC . 
All study -related information will be kept in double -locked , limited access areas at  the study site. A log 
that links the names of participants to their SID number  will also be kept under double locks and separate 
from all other research records , accessible only to the study staff, ATN site monitors, and representatives 
from the NICHD. Original source documents for individual participants  will be maintained at the study 
site and will be accessible only t o the study staff. Data from original source documents will be transcribed 
on CRFs as applicable.   
Individuals who complete the pre-screening process but who do not consent to participate will only have 
information collected on the ATN 151 Screening Form , which  will be entered into the study database 
using a method to maintain anonymit y. 
7.3  Data Collection  and Submission  
Research staff will be responsible for ensuring that CRF data is entered into CDART within one calendar 
week of data collection  in a timely manner . Data edits through range checks and field inconsistencies will 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
25 be built into the CDART database to enable real time correction of key entries and CRF completion 
errors.  
All data collected using  ACASI will be  developed within the CDART  web-based system . The 
participant’s SID will be used in order to link the interview responses to the participant’s CRF data. The 
ACASI data will be collected on Apple iPad devices using Qualtrics and the CDART data management 
tool. Data are stored on secure server s maintained by th e ATN CC. No data is written to the iPad hard 
drive. Since data are persisted to the secure servers during data collection, if a network failure occurs 
during an interview little to no data will b e lost. The secured servers comply with FIMSA regulations  and 
are tightly controlled , and inaccessible to any person or application without appropriate credentials.  
Focus group  and key informant interviews will be digitally audio -recorded with participant consent. 
Immediately upon completion, th e digital audio files will be uploaded to a secure server. The audio 
recordings will be uploaded to a secure website belonging to a transcription company  (CastingWords) , 
who will listen to the recordings, transcribe them into a Microsoft Word file, and upl oad the transcript 
files to their secure website for download by study staff. Transcripts will be checked against audio 
recordings for accuracy. Once that process is complete, the audio files will be destroyed. Dr. Hill  will 
ensure that the audio files are  destroyed by the transcription company, and permanently deleted from the 
University of Chicago OBGYN  server.  
Data fr om focus groups and key informant interview s will be transferred to the ATN CC. This data and 
all data collected using CDART will be submi tted to the NICHD’s Data and Specimen Hub (DASH) after 
completion of the study in accordance with the NICHD DASH Data Archive Policy 
(https://dash.nichd.nih.gov/Resource/Policies ) and the NIH Gra nts Policy Statement 
(https://grants.nih.gov/grants/policy/nihgps/HTML5/introduction.htm ).  
7.4 Data Quality Assurance  
Investigators receiving federal funding must adhere to  the Code of Federal Regulations (CFR) to protect 
research participants and produce reliable study information. Sites participating in research sponsored by 
the NICHD need to have an internal Q uality Assurance (QA) plan that will identify problems and correct 
errors in research study records. ATN sites will specify their QA plan at protocol registration in the 
Protocol Implementation Plan.   
7.5 Role of Data Management  
The CC will provide instructions co ncerning ACASI administration, the recording of study data on CRFs , 
data entry , and data transmission to the CC via CDART at the completion of the study. It is the 
responsibility of the CC to assure the quality of computerized data. This role extends from protocol 
development to generation of the final study databases.  
7.6 Study Site Monitoring and Record Availability  
Site monitors from the CC will visit participating study sites to review participant records, ICFs , CRFs 
and supporting source documentation,  compliance with the protocol, and the accurac y and completeness 
of records. Regulatory files, as required, will also be inspected to ensure that regulatory requirements are 
being followed.  
The site investigator will make study documents (e.g., CRFs , ICFs ) and pertinent source  records  readily 
available for inspection by the local IRB, the site monitors, the NICHD, the Office of Human Research 
Protection (OHRP), or the sponsor’s designee for confirmation of the study data.  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
26 8.0 PARTICIPANT MANAGEME NT 
8.1 Tracking Participants / Follow -up 
Site study staff will track participant study recruitment and retention for all study  visits , as well as 
intervention sessions completed by participants.   
8.2 Study Visit Management  
After the Baseline visit, participants have up to 12 weeks to complete workshop classes  for Phase 2 and up to 4 
weeks for Phase 3 , otherwise they may go on to complete the post-intervention and follow -up visits  as outlined 
below . Participants who do not complete any workshop classes may still c omplete the follow -up visit. 
Participants may withdraw from the study at any time , and may be considered lost to follow up if they are 
unable to be reached after a minimum of three documented contact attempts.  
 For p articipants  that complete all 4 workshop sessions,  the post -intervention visit  will need to be 
completed w/in 2 weeks of the last workshop session , otherwise they may go on to complete the 
follow -up visit  at 8 months (±4 weeks) after the last workshop session  for Phase 2 and at 3 months (±2 
weeks ) for Phase 3 .  
 For participants  that complete  at least one but less than all four  of the workshop sessions  in the time 
allowed (within 12 weeks of baseline for Phase 2, and 4 weeks for Phase 3) , the post -intervention visit  
will need to be completed withi n 14 weeks of Baseline for Phase 2 and within 6 weeks for Phase 3. 
Otherwise , participants  may go on  to complete the follow -up visit at 8 months  of the last class 
completed ( ±4 weeks ) for Phase 2, and 3 months  of the last class completed (±2  weeks ) for phase 3.   
 For participants  that do not complete any workshop sessions, the follow -up visit will need to be 
completed at 8 months (±4 weeks)  after Baseline for Phase 2, and 3 months (±2 weeks)  for Phase 3 .  
8.2.1  Completing the Audio Computer Assisted Self -Interview  
 The participant is reminded of his or her right to discontinue at any time with no penalty and 
the right to choose to leave any questions unanswered;  
 The participant is given headphones and a iPad in an accommodating, private and quiet area;   
 The research  staff assists with ACASI tutorials;  and 
 If the participant requires a break, research  staff will make sure the computer program is exited 
and re -entered properly so that the participant’s privacy is maintained   
8.2.1  Debriefing and Referral Pr ocedures for Audio Computer Assisted Self -Interview Participants  
 The participant will be debriefed about possible reactions to answering questions of a sensitive 
nature, such as short -term feelings of sadness or anxiety. Participants will be instructed to 
contact study personnel or to consult the list of referrals provided if feelings persist or worsen 
after several days;  
 Referrals for mental health services will be provided to all participants, if warranted; and  
 At the completion of the ACASI, the  research  staff member present during the session will ask 
the following question:  “Is there anything else about the interview that you would like to 
discuss?”  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
27 If the respondent says “no,”  they should  be thanked for participation. The respondent will be given 
contact information for mental health personnel available at UC and informed that they can also 
contact study personnel in the event that issues or concerns arise later.   
If the response indicates the participant is in urgent need of mental health assistance, site staff should 
follow their individual site procedures for acute mental health referrals. Site staff s hould contact a 
supervisor immediately and stay with the study participant until the supervisor, mental health 
profes sional or emergency s ervices, if needed, arrives. Otherwise, the interviewer should say, "If you 
decide that you would like to speak with a counselor, here is the contact information for a counselor 
and a list of agencies in the community that provide this  service” and provide the list of referrals.  
8.3 Compensation  
Focus Groups :  Participants will receive $40 each for focus group participation. 
Key Informant Interviews : LGBTQ -friendly employers will be offered a $10 gift card for key informant 
interview participation. All other p articipants will receive $40 for key  informant interview participation. 
CAB :  $30 per meeting.  
Intervention P re-Test: Participants will receive $30 for completing visit  survey s at T1 and T2,  $40 for 
providing optional biologic specimens  at T1,  and $20 per workshop se ssion attended, for a possible total 
of $180. 
Intervention Pilot : Participants will receive $30 for completing visit  survey s at each time  point,  $40 for 
providing optional biologic specimens  at T1 and T 3, $40 per workshop se ssion attended, for a possible total 
of $330.  
Intervention Community Pilot : Participants will receive $30 for completing visit  survey s at each time 
point,  $40 for providing optional biologic specimens  at T1 and T3, and $30 per workshop se ssion attended, 
for a possible total of $290.  
8.4 Intervening on “Social Harms"  
8.4.1  Potential risks 
Potential risks consist of participants being uncomfortable or emotionally upset  as a result of the questions 
asked in the assessments, and potential breaches  of confidentiality. However, participants are allowed to 
discontinue  the study at any  time and to not respond  to questions they are uncomfortable with, without 
any pena lty. All information disclosed to the research team will remain confidential, even if a participant 
chooses  to withdraw from  the study. Additionally, study participants can ask study staff to provide any 
needed  referrals to counselors or other suppo rt if they beco me emotionally upset. Study participants will 
also have access  to a clinician or soc ial worker who can help them address any feelings and/or questions 
which arise over the course of their participation. The investigative team has condu cted studies with 
hund reds of assessment visits and has managed all visits succes sfully. Proced ures for youth who do 
experience discomfort are detailed below. 
All study records that identify the participant will be kept co nfidential, however there is a risk of loss of 
confidentiality such as by manda ted reporting of child abuse /neglect for participants 16-17 years old. All 
healthcare professionals are required by law to report suspe cted cases of abuse  and/or neglect. Although 
several of the proposed  assessment measures include elicit information about e xperiences  of 
discrimination and sexual beha viors, they do not specifically address child abuse  or neglect. Thus, a report 
of abuse  or neglect will only occur  if the participant knowingly volunteers this information. In addition, 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
28 all participants are told in the consent p rocess that statements of potential ha rm-to-self or others may 
require further assessment and/or reporting. The research team has  specific procedu res in place for 
referrals and strict co nfidentiality reporting. 
Additionally, a potential risk to confidentiality may occur if a participant tests positive for HIV or an  STI 
during the cou rse of the study. All participants will be told of reporting requirements during the consent 
process. If a participant tests positive for HIV or an  STI, s/he will be referred to the Chicago Center for 
HIV Elimination (CCHE) for confirmatory HIV testing and appropriate care. CCHE is required to report 
all new cases of HIV by name and contact information to the Illinois Department of Public Health. Other 
information, including risk factors and sex contacts, are also requested for pa rtner services. As an 
additional s afeguard, the proposed study has two practicing physicians who have extensive experience 
treating STIs and HIV/AIDS among YMSM and YTW of color. 
There is a general potential risk of a breach in confidentiality of participant information. However, all 
investigators and study staff have been  involved in several local and  national s tudies of YMSM and YTW 
and ha ve considerable experience implementing measures to protect participant confidentiality. Some of 
these s teps include signed confidentiality agreements, in-service training on confidentiality, and the 
assignment of study ID numbers for all participants. Additionally, all front-line research staff who will be 
working with the pa rticipants throughout the project will unde rgo routine ethics training and complete 
specialized confidentiality training around  HIV and other sens itive issues  through the Chicago 
Department of Public Health. All staff will have completed training regarding HIV prevention and PrEP 
access  through the AIDS Found ation of Chicago’s (AFC) “Ready  Set PrEP!” shou ld participants request  
additional information on these services. All staff will complete the Midwest AIDS Training and 
Education (MATEC) training and CDC Passpo rt to Partner Services HIV and  STI Prevention training 
prior to implementation. All data will be collected on secure network hosted by the university techno logy 
services. 
8.4.2  Potential coercion  
Any study that pa ys a stipend  may produce coercion. Eliminating the possibility of coe rcion by not 
awarding stipends  would make it impossible to condu ct many studies, and would shortchange sub jects 
who provide time and energy, and may incur costs such as bus, train or ca b fares. The resolution to this 
problem is to ensure that stipends  are not inappropriately large, to probe potential sub jects to make sure 
they have not been  coerced, and to give persons who may have been  coerced the opportunity not to 
enroll in the study in a manner that will protect them from retribution by the person coercing them. We 
believe we meet these cond itions. The employment program session stipends  proposed are similar to 
other studies used by members of the investigative team, and have not raised issues of coerciveness. 
8.4.3  Protection against risk  
8.4.3.1  Discomfort or distress during the research   
Because  there is a potential for discomfort or distress due to the research topic, we will make every effort 
to create a secure environment (ensuring privacy) prior to conduc ting base line and follow-up assess ments 
and intervention sessions. Participants will be told that they do not ha ve to answer any question they do 
not wish to. Participants experiencing mild distress during the assessments will be offered a small break or 
will be reschedu led to complete the asses sment at a later da te. In the unlikely event that a  participant 
experiences  considerable distress, we will make a referral (if needed)  for clinical assess ment and/or 
counseling provided at each of the primary sites. Participants will be given the names and office phone  
numbers of the assessor, the Site Lead, and the Project Coordinator, and  will be provided with referrals 
for mental hea lth and supp ort services. The Site Lead  will be on-call for any  serious problems that a rise 
during asses sments and intervention sessions. 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
29 8.4.3.2  Disclosure  of abuse, homicide or suicide risk  
A number of proced ures will be taken to minimize risk to participants. The conse nt procedu res will 
explicitly state that participation in the research is voluntary, and that questionna ires will include items 
about sexual h istory, substance use, and sexual risk beha viors. Participants will be informed of the 
confidentiality of their respons es as well as the limits of that confidentiality. If a participant d iscloses 
suicidal ideation, any type of violence,  or homicidal intent, the research team will assess  the level of risk 
and determine the best course of action (e.g., sending the participant to the emergency room, notifying the 
police). Youth under age 18 will be informed that disclosure of violence or victimization relating to a 
family member will require an evaluation by onsite beha vioral hea lth staff to determine the best cou rse of 
action, and that under cond itions of immediate danger or harm may require reporting or notification to 
appropriate authorities (i.e. the police or the Department of Children and Family Services). A 
determination of the decision-making capac ity of the participants will be done  prior to obtaining conse nt 
and research staff will pay  particular attention to participants’ understanding of the risks assoc iated with 
disclosure of information and the implications of that disclosure in accordance  with state law. 
During all study visits, there will be an on-site behavioral hea lth clinician or social worker to provide 
clinical bac kup to the RA, particularly conce rning issues  of child abuse, neglect, and suicidality. The on-
site beha vioral hea lth staff will have specific clinical expertise in managing the unique challenges facing 
young  sexual and gender minorities. Consistent with abuse  and/or neglect reporting requirements, shou ld 
a report to the au thorities be required, the information provided will be from the Project Lead at each  site. 
No mention of the youth’s participation in this particular research project will be disclosed.  We will 
inform pa rticipants that criminal beha vior (i.e. drug use) is not reported to authorities and that the 
information is entirely confidential. These p rocedu res will be reviewed in writing and in person by the RA 
as part of the informed conse nt process to help youth assess  whether they wish to participate in the 
research, and  to minimize the inadvertent d isclosure of information. Regardless of age, if a participant 
discloses suicidal ideation or intent, the beha vioral hea lth clinician or social worker will be available to 
assess the level of risk and to help determine the best cou rse of action (e.g. send  to the emergency  room). 
8.5 Criteria for Premature Discontinuation  
Participants may choose to withdraw themselv es from the study at any time. The study is voluntary and 
the alternative to participating in any phase of the study is not participating.  
9.0 MONITORING & REPORTING SAFETY  EVENTS   
Site staff must follow their oversight  IRB's procedure for reporting and managing safety  events , as well as 
the ATN CC procedures outlined below  and in Chapter 10 of the ATN Manual of Policies and Procedures 
(MOPP) . Safety events  are reported  using the ATN QNS accessible through the  ATN website 
(https://www2.cscc.unc.edu/atn/ ). All safety events will be reviewed by the study team and reported to 
NIH.  
9.1 Study Team Review  
Given that this study is a short pilot study of a behavioral intervention with a single arm (a pre -/post 
study), this study will use  study team review for  clinical research monitoring (CRM), where the study 
team consists of the Protocol Team at UC , a NIH re presentative, and the Coordinating Center (CC) at 
UNC Chapel Hill. Safety  events will be reviewed by the study team on a case -by-case basis  at team 
meetings which will occur at least mont hly. The members of the study team and data to be reviewed at the 
meetings are described below.     
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
30 Study team members:  
 Protocol Chair (s)  
 ATN Coordinating Center Investigator  
 Protocol Manager  
 Project Manager  
 NIH Representative  
During the study team meetings,  data quality and participant safety (e.g., number and type of  safety 
events , recruitment and retention ) will be reviewed  and the team will determine what actions are 
necessary , if any . The study team will also previously reported safety events  for which new information is 
available . 
The CC will monitor accrual and retention based on reports which they will generate monthly . Reports 
will include accrual, baseline characteristics, data quality, and completeness.  If there are any problems 
with accrual or retention rates at specific sites, the CC will work with the site to identify operational 
issues or problems and take appropriate action.  
9.2       Reportable Safety Event s  
There are three types of reportable safety events  that require expedited reporting in QNS (within 2 
reporting days of sit e awareness) :  
1. Adverse events (AEs) deemed to be possibly related or definitely related to the study that are 
severity grade 3 or higher  
2. All s erious adverse events (SAEs)  
3. Untoward events (UEs) deemed to be possibly related or definitely related  to the study that are 
severity grade 3 or higher  
Please note that all community UEs (not graded) and UEs grades 1 -2, as well as AEs grades 1 -2, do not 
require expedited reporting. These types of events must be reported within 5 reporting days of site 
awarene ss, and are up to the discretion of the site investigator and protocol team as to whether or not they 
are reportable.  
Once entered into QNS and after study team review, s afety event reports should be printed and filed with 
participant records (or with reg ulatory documents if not related to a specific participant ). In addition, 
study staff must also follow their oversight IRB procedures for reporting and managing safety events.  
For more information regarding the definitions of each type of  safety event  and details on reporting, 
please refer to the ATN CC MOPP Chapter 10.  
9.3 Safety Event Reporting Periods  
Safety events must be reported throughout the duration of a study. If the event involves a specific study 
participant, events must be reported for the du ration of that participant’s enrollment in the study. After the 
protocol -defined reporting period ends, only events that study staff become aware of on a passive basis 
(from publicly available information) should be reported.  
The duration of the reporting period for community UEs events begins at project start -up and continues 
through any professional or lay publication of study findings. If the online reporting system is not 
available after study closure, electronic reports should be made directly to Progr am Staff at NICHD.  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
31 All potential safety events should be reported as soon as possible after site staff become aware of the 
event. Events that require expedited reporting ( are grade 3 or higher or SAEs of any grade) must be 
reported within 2 reporting days (see guidance below) of site awaren ess. Grades 1 & 2 events and all 
community UEs must be reported within 5 reporting days of site awareness.  
Reporting Days:  
• A reporting day starts at 12:00 AM (midnight) and ends at 11:59 PM local time.  
• A day is counted a s a reporting day regardless of the time of day that awareness occurred. The 
day a site indicates that site personnel became aware of an EAE that meets reporting criteria shall 
count as day 1 if that day occurs on a reporting day (i.e., Monday through Frid ay). If that day 
occurs on a non -reporting day (i.e., Saturday or Sunday), then the next reporting day shall count 
as day 1.  
• Monday through Friday count as reporting days.  
• Saturday and Sunday are not considered reporting days.  
• Any holiday that occurs on a Monday through Friday counts as a reporting day.  
10.0 STATISTICAL/ANALYTIC  CONSIDERATIONS  
10.1 Study Design  
This protocol uses t hree distinct phases, each with its own study design. Phase I will consist of qualitative 
research using focus groups of both: (1) the study population (i.e., YMSM and YTW); and (2) employers 
of the study population. The goal of Phase I is to tailor the interv ention, designed to increase employment 
in an adult population, to the study population.  
Phase II and III of the protocol will use a pre -/post design to determine preliminary efficacy of the revised 
intervention tailored to youth and designed to increase e mployment. Additional secondary outcomes, and 
potential mediators and effect modifiers of the intervention, will be considered.  
10.2 Sample Size and Power  Estimates  
Given the exploratory nature of this study and limited access to this population , a power c alculation was 
not performed . A repeated measures design was chosen to reduce the variability in the estimate of the 
treatment effect, at the expense of having a comparison group. This trade -off was appropriate given the 
exploratory nature of a pilot study  and the limited access to the study population . 
10.3  Statistical Analysis Plan  
10.3.1  Data Analysis  
The analytic plan is designed to : (1) tailor the adult intervention to youth; (2) assess intervention 
feasibility, acceptability, and satisfaction ; and (3) determine preliminary efficacy of the intervention by 
compar ing pre-/post  assessments of employment  and sexual  risk behaviors . 
Phase I  
Data collection, storage, and analysis will take place at the study site (University of Chicago) and will be 
the resp onsibility of the Protocol Chair.  
Interviews and focus groups will be transcribed and coded by trained qualitative researchers. These 
transcripts will be coded for patterns and themes that emerge from the data, and these data will be used to 
inform the rev ision of the employment intervention that will then be pilot -tested. All focus groups and 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
32 key informant interviews will be digitally audio -recorded, transcribed (verbatim), and analyzed using 
emergent inductive logic data  aggregation and analysis in Atlas. ti 7.0. Major emergent themes will be 
used to create a codebook and two -independent coders will analyze all data separately and compare 
coding schema for internal reliability (Kappa) (Aim 1). Descriptive statistics will be used to analyze the 
proportions a nd central tendencies  for all feasibility, acceptability, and satisfaction measures: helpfulness, 
comprehensibility, quality, content appropriateness, engagement, utility, satisfaction, belief in efficacy, 
and recommendation to a friend.  
Datasets for Phase  I will be cleaned, verified and archived, and then entered into SPSS for analyses. All 
database files will be password -protected and backed up to a secure university server daily.  
Phase II  and III  
10.3.1.1 Descriptive statistics  
Descriptive statistics wil l be used to analyze the proportions and central tendencies for participant 
sociodemographic characteristics collected in the surveys completed by participants in the pilot -tests. We 
will first generate frequencies, means, and other measures of central tendency as appropriate to describe 
our sample and outcomes at each of the three time points (T1, T2, T3). Sensitivity analyses will be 
performed to address extreme outlying variables , including the removal of records with extreme outlying 
values from analyses.  
Changes in primary and secondary outcomes between Baseline (T1) and Follow -Up (T3) will be assessed 
using paired t -tests for continuous variables and McNemar’s test for categor ical variables . Other statistical 
tests that appropriately account for the correlation in the dataset will be considered as needed.  All 
hypothesis testing will be done at an alpha -level of 0.1, given the pilot/exploratory nature of the study.  
10.3.1.2 Modeling 
The primary goal of the modeling will be to help evaluate what characteristics could be mediators or 
effect modifiers of the effect of the intervention . Continuous outcomes will be analyzed using linear 
regression or generalized linear models, discret e outcomes will be analyzed using Poisson regression, and 
logistic regression will be used for binary and categorical outcomes . Only variables that have a 
statistically significant univariate relationship with the given outcome, at an alpha -level of 0.2, w ill be 
considered as potential mediators or effect modifiers for the effect of the intervention . 
Datasets for Phase 2 and 3 will be collected using CDART and cleaned, verified and archived by the ATN 
CC.  
10.4 Missing, Unused and Spurious Data  
Every effort  will be made to ensure that the amount of missing data is kept to a minimum , as missing data 
can complicate the statistical analyses and/or result in biased parameter estimates.  
Several procedures will be used to conduct data analysis when data for eithe r outcomes or covariates are 
missing. The first step will be to assess the extent and pattern of missing data. If data are missing for only 
a few cases, then data analysis will be conducted only on study participants with complete data. However, 
when such a strategy would result in loss of data from a substantial proportion of participants, or if this 
approach would lead to biased or inaccurate results, then multiple imputation will be used.   
When the primary endpoint is missing, one data analysis will be c onducted using only cases with the 
endpoint.  
Participants who do not complete all of the workshops will still be included in the analysis if they attend 
the follow up visit (T3), in a similar manner as intent -to-treat, where individuals are assumed to have 
received the intervention that was intended.  We will also conduct a sensitivity analysis excluding these 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
33 participants, in an attempt to understand their potential impact on the preliminary estimates of 
intervention efficacy.  
11.0 HUMAN SUBJECTS  
This study will be conducted in compliance with the pro tocol, ICH Good Clinical Practice guidelines, and 
45 CFR Part 46.  
11.1 Participant Confidentiality  
All laboratory specimen s, ACASI visit surveys, evaluation forms, and other research -related records will 
be identified by SID only to maintai n participant confidentiality. Only contact information approved by 
the study participant will appear on any study contact forms  and reports, and these will be securely 
maintained by both the site and the CC. All records with personally -identifying informa tion will be 
maintained under double locks at the study site, with access limited to designated site research personnel.  
Any study records that need to be transported between community sites and the study site will be securely 
maintained in locked boxes  and transported only by authorized personnel listed in a Note to File .  
Any l aborator ies used to test biological specimens will not have any study -specific identification recorded 
on their labels or associated requisition forms. Study data  will not be releas ed without written permission 
of the participant (and parent or legal guardian, when applicable), except as mandated by the law . 
Once all data has been  collected, identifying participant  information (including name) will be stripped  
from the database. Consents will only be access ible to designated research staff, and stored in a locked 
filing cabinet in secure offices.  
Computer files consisting of the participant tracking database, study data files, and  transcriptions will be 
stored on a UNC  server. The participant tracking database  contains contact information and is used to 
schedu le and track study visits, and is completely pass word protected. The tracking database does not 
contain any clinical (i.e., personal  health information) or research-based  information; it only has 
information the participant has agreed to provide for the pu rposes  of tracking and communication. 
Data files are exported from the web-based  ACASI program (administered on a web-based  iPad platform) 
to a UNC  server and imported into the CDART  database  for storage and analysis. Transcripts are entered 
into Atlas.ti for storage and analysis also on the UNC  server. Data files do not include information that 
could be used to identify the participant from the data file alone. CDART is protected with indus try 
recognized security standards which will enc rypt data and will be further protected by login creden tials 
for limited access, to protect participant co nfidentiality. 
11.1.1  Record Retention  
All data will be destroyed 7 years after the study is completed  or per NIH and/or institutional guidelines, 
whichever is more conserva tive. Identifiers will be stripped from  any study databases or logs at the 
completion of the study.  
11.2 Certificate of Confidentiality  
To further protect the privacy  of the study participants, the ATN has obtained a Certificate of 
Confidentiality from the U.S. Department of Hea lth and Human Services (DHHS). With this Certificate 
in place, the ATN researchers cannot be forced to turn over identifying information about a study 
participant in any Federal, State, or local criminal, administrative, legislative, o r other proceedings. This 
Certificate does not prevent a study participant from volunteering to turn over their research information 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
34 nor does it prevent researchers  from providing research -related information to others when req uested by 
the study participant  (Appendix  V). 
11.3 Risks and Benefits  
11.3.1  Risks  
Participants in this  study are exposed to few risks. The primary risks are loss of confidentiality and 
potential discomfort  or embarrassment in discussing some of the sensitive and personal topics probed in 
the intervie ws, focus groups, and surveys. Data and safety monitoring  will be performed by the trained 
data collectors and research team to assure that data are entered completely and participant confidentiality 
is maintained. If necessary, research staff will complete an Untoward  Event report and immediately 
inform the Principal Investigator, so that s /he can ensure accurate reporting to the IRB. Finally, the 
Principal Investigator will include a summary of all Untoward  Events as part of continuing IRB review .  
Risks to participants in this research study may include:    
Risk Category: Research not involving greater than minimal risk (45 CRF §46.404 and 21 CFR §50.51 )  
Participation in this study poses no more harm or discomfort to research participants than they may 
experience in normal daily life or during routine physical or psychological examinations or tests.  
Participation in this study does not involve any physica l risk. However, there is some risk of emotional 
discomfort or distress due to the personal nature of some questions. Participants will be informed that 
they are free to decline to answer any questions, or withdraw from participation at any time without 
penalty. Participants will be instructed to contact study personnel or to consult the list of referrals 
provided if feelings persist or worsen after several days. If the response indicates the participant is in 
urgent need of mental health assistance, site s taff should follow their individual site  procedures for acute 
mental health referrals. Site staff s hould contact a supervisor immediately and stay with the study 
participant until the supervisor, mental health professional , or emergency services, if needed , arrives . 
11.3.2  Benefits   
Information from this study may benefit other youth, now or in the future, by understanding methods to 
motivate HIV -positive young people to start and adhere to their prescribed HIV treatments.  
11.4 Institutional Review Board ( IRB) Review and Informed Consent  
This protocol, the informed consent documents , and any s ubsequent modifications will be  reviewed and 
approved by the IRB or ethics committee responsible f or the oversight of the study. The informed consent 
will describe the  purpose of the study, the procedures to be followed, and the risks and benefits of 
participation.   
Signed  informed consent will be obtained from the participant (or parent, legal guardian, or person with 
power of attorney for participants who c annot consent for themselves). The participant ’s assent must also 
be obtained if he or she is able to understand the nature, significance, and risks of the study. The signed 
original consent/assent form will be kept on file at the site and a copy of the co nsent/assent form will be 
given to the participant and to the parent or legal guardian, if applicable.   
11.4.1 R isk Category: Minimal Risk  
Permission will be sought from at least one parent or guardian in accordance with local IRB/EC approved 
procedures unless the IRB/EC has waived the requirements for obtaining parental or guardian permission 
in accordance with 45 CFR §46.408 (c).  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
35 Assent of the children involved in this study will be sought in accordance with the regulations at 45 CFR 
§46.408(a) or 21 C FR §50.55 and local IRB/EC -approved policies and procedures.  
11.5 Waiver of the Requirement for Parental Permission for Special Circumstances   
Participating site IRB s will be requested to grant a waiver of parental/legal guardian consent to participate 
in this research study for youth participants under the age of legal majority based on state or local laws.  
Under 45 CFR Part 46.4116 (c), an IRB has the authority to waive parental permission if it determines 
that “a research protocol is designed for condit ions or a subject population for which parental or guardian 
permission is not a reasonable requirement to protect the subjects” and “an appropriate mechanism for 
protecting the children who will participate as research subjects is substituted” and “that th e waiver is not 
inconsistent with Federal, state, or local law.”  
The protocol team would submit that:  
 This study is not conside red greater than minimal risk. Participants will complete surveys and supply  
specimens for routine HIV monitoring. None of the content of this study is beyond what would be 
covered during routine medical or psychological visits or procedures related to the pr oblem behaviors 
being studied. The probability of harm from participating  in this study is no greater than that 
occurring in routine care.  
 The ATN site involved in the study and most other community agencies offering HIV -related services 
are confidential and do not require parental/legal guardian notification or permission to t reat under 
state regulations.  
 Contacting a parent/legal guardian could constitute a breach of confidentiality for these HIV -positive 
participants and could potentially put some HIV -positive youth at risk for abuse or ousting from the 
home if parents/guardi ans are not aware of their HIV status.  
 It is expected that there will be participants who have not disclosed their HIV status to 
parents/guardians nor will the parents/guardian be aware of the  participant’s risk behaviors. A 
requirement for parental permis sion in this type of study could not only affect a person’s willingness 
to participate, but could also potentially impact the ability of researchers to engage in this type of 
HIV-related research with youth.  
 Adequate protection has been substituted by the mechanisms in place to protect the privacy and 
confidentiality of participants and by the treatment referrals offered if needed.  
Under Illinois law (410 ILCS 305/9) minors can consent to STI and HIV testing without the consent or 
knowledge of said minor’s parent.   
11.6 45 CFR Parts 160 and 164 Standards for Privacy of Individually Identifiable Health 
Information ("Privacy Rule" Pursuant to the Health Insurance Portability and 
Accountability Act - HIPAA)  
Site is responsible for adherence to their individual  institution’s HIPAA policies and procedures.  
11.7 Study Discontinuation  
This study may be discontinued at any time by the NICHD .  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
36 12.0 PUBLICATION OF RESEA RCH FINDINGS  
NICHD and ATN policies will govern publication of the results of this study. Publication of the results of 
this trial will be governed by the ATN Publications Policy, which will be established by the Publications 
Committee. Any presentation, abstract or ma nuscript will be made available for review by the 
Publications Committee prior to submission.   
13.0 BIOHAZARD CONTAINMEN T  
As the transmission of HIV and other blood borne pathogens can occur through contact with 
contaminated needles, blood, and blood products, appropriate blood and secretion precautions will be 
employed by all personnel in the drawing of blood and shipping and handling of all specimens for this 
study, as currently recommended by the Centers for Disease Control and Prevention . These pro cedures 
can be found at www.cdc.gov .   
 
ATN specimens will be transported in accordance with Federal and local laws, and in compliance with 
OSHA blood -borne pathogens standards  as applicable . This policy includes the samp les being transported 
by ground to the local laboratory.  Compliance will be achieved by education of personnel involved with 
packag ing and transporting specimens.  
 
14.0 REFERENCES  
Auerbach, J. D., Parkhurst, J. O., & Caceres, C. F. (2011) . Addressing social drivers of HIV/AIDS for the 
long-term response: conceptual and methodological considerations. Glob Public Health, 6 Suppl 
3, S293 -309. doi:10.1080/17441692.2011.594451  
Baral, S. D., Poteat, T., Stromdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013). Worldwide 
burden of HIV in transgender women: a systematic review and meta -analysis. Lancet Infect Dis, 
13(3), 214 -222. doi:10.1016/S1473 -3099(12)70315 -8 
Bauer, G. R., Travers, R., Scanlon, K., & Coleman, T. A. (2012). High heterog eneity of HIV -related 
sexual risk among transgender people in Ontario, Canada: a province -wide respondent -driven 
sampling survey. BMC Public Health, 12 , 292. doi:10.1186/1471 -2458 -12-292 
Bockting, W. O., Miner, M. H., Swinburne Romine, R. E., Hamilton, A., & Coleman, E. (2013). Stigma, 
mental health, and resilience in an online sample of the US transgender population. Am J Public 
Health, 103 (5), 943 -951. doi:10.2105/AJPH.2013.301241  
Bradfo rd, J., Reisner, S. L., Honnold, J. A., & Xavier, J. (2013). Experiences of transgender -related 
discrimination and implications for health: results from the Virginia Transgender Health Initiative 
Study. Am J Public Health, 103 (10), 1820 -1829. doi:10.2105/A JPH.2012.300796  
Brennan, J., Kuhns, L. M., Johnson, A. K., Belzer, M., Wilson, E. C., Garofalo, R., & Adolescent 
Medicine Trials Network for, H. I. V. A. I. (2012). Syndemic theory and HIV -related risk among 
young transgender women: the role of multiple, c o-occurring health problems and social 
marginalization. Am J Public Health, 102 (9), 1751 -1757. doi:10.2105/AJPH.2011.300433  
A Broken Bargain for LGBT Workers of Color . (2013). Retrieved from h ttp://www.lgbtmap.org/policy -
and-issue -analysis/workers -of-color  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
37 CDC. (2012). Estimated HIV incidence in the United States, 2007 -2010.  Retrieved from 
http://www.cdc.gov/hiv/topics/surveillance/resources/reports/#supplemental  
CDC. (2013). HIV Surveillance - Adolescents and Young Adults. Retrieved from 
http://www.cdc.gov/hiv /pdf/statistics_surveillance_Adolescents.pdf  
Clements -Nolle, K., Marx, R., & Katz, M. (2006). Attempted suicide among transgender persons: The 
influence of gender -based discrimination and victimization. J Homosex, 51 (3), 53 -69. 
doi:10.1300/J082v51n03_04  
Durso, L. E., Kastanis, A., Wilson, B. D. M., & Meyer, I. H. (2013). Provider Perspectives on the Needs 
of Gay and Bisexual Male and Transgender Youth of Color . Retrieved from Los Angeles, CA:  
http://williamsinstitute.law.ucla.edu/wp -content/uploads/ACCESS -final-rev-aug-2013.pdf  
Dyer, T. P., Regan, R., Wilton, L., Harawa, N. T., Ou, S. S., Wang, L., & Shoptaw, S. (2013). Differences 
in substance use, psyc hosocial characteristics and HIV -related sexual risk behavior between 
Black men who have sex with men only (BMSMO) and Black men who have sex with men and 
women (BMSMW) in six US cities. J Urban Health, 90 (6), 1181 -1193. doi:10.1007/s11524 -013-
9811 -1 
Fletc her, J. B., Kisler, K. A., & Reback, C. J. (2014). Housing status and HIV risk behaviors among 
transgender women in Los Angeles. Arch Sex Behav, 43 (8), 1651 -1661. doi:10.1007/s10508 -014-
0368 -1 
Garofalo, R., Osmer, E., Sullivan, C., Doll, M., & Harper, G. ( 2006). Environmental, psychosocial, and 
individual correlates of HIV risk in ethnic minority male -to-female transgender youth. Journal of 
HIV/AIDS Prevention Children & Youth, 7 (2), 89 -104.  
Gayles, T., Kuhns, L., Kwon, S., Mustanski, B., & Garofalo, R. (2 016). Socio -economic disconnection as 
a risk factor for increased HIV infection in young men who have sex with men (YMSM). Journal 
of LGBT Health .  
Grant, J. M., Mottet, L. A., Tanis, J., Harrison, J., Herman, J. L., & Keisling, M. (2011). Injustice at 
Every Turn: A Report on the National Transgender Discrimination Survey . Retrieved from 
Washington, D.C.:  
Herbst, J. H., Jacobs, E. D., Finlayson, T. J., McKleroy, V. S., Neumann, M. S., Crepaz, N., & Team, H. 
A. P. R. S. (2008). Estimating HIV prevalence and risk behaviors of transgender persons in the 
United States: a systematic review. AIDS Behav, 12 (1), 1 -17. doi:10.1007/s10461 -007-9299 -3 
HRC. (2015). Corporate Equality Index 2015: Rating American workplaces on lesbian, gay, bisexual, 
and transgender eq uality . Retrieved from h ttp://hrc -assets.s3 -website -us-east-
1.amazonaws.com//files/documents/CEI -2015 -rev.pdf   
IOM. (2011). The Health of Lesbian, Gay,  Bisexual, and Transgender People: Building a Foundation for 
Better Understanding . Retrieved from Washington, D.C.:  
Kammerer, N., Mason, T., Connors, M., & Durkee, R. (2001). Transgender health and social service 
needs in the context of HIV risk. In W. O.  Bockting & S. Kirk (Eds.), Transgender and HIV 
Risks, Prevention, and Care  (pp. 39 -57). New York, NY: Haworth Press.  
Kipke, M. D., Weiss, G., & Wong, C. F. (2007). Residential status as a risk factor for drug use and HIV 
risk among young men who have sex with men. AIDS Behav, 11 (6 Suppl), 56 -69. 
doi:10.1007/s10461 -006-9204 -5 
Lomabrdi, E. L., Wilchins, R. A., Priesing, D., & Malouf, D. (2002). Gender violence: Transgender 
experiences with violence and discrimination. Journal of Homosexuality, 42 (1), 89 -101.  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
38 Melendez, R. M., Exner, T. A., Ehrhardt, A. A., Dodge, B., Remien, R. H., Rotheram -Borus, M. J., . . . 
Hong, D. (2006). Health and health care among male -to-female transgender persons who are HIV 
positive. Am J Public Health, 96 (6), 1034 -1037. doi:10.210 5/AJPH.2004.042010  
Melendez, R. M., & Pinto, R. (2007). 'It's really a hard life': love, gender and HIV risk among male -to-
female transgender persons. Cult Health Sex, 9 (3), 233 -245. doi:10.1080/13691050601065909  
Meyer, I. H. (2003). Prejudice, social stre ss, and mental health in lesbian, gay, and bisexual populations: 
conceptual issues and research evidence. Psychol Bull, 129 (5), 674 -697. doi:10.1037/0033 -
2909.129.5.674  
Millett, G. A., Jeffries, W. L. t., Peterson, J. L., Malebranche, D. J., Lane, T., Flor es, S. A., . . . Heilig, C. 
M. (2012). Common roots: a contextual review of HIV epidemics in black men who have sex 
with men across the African diaspora. Lancet, 380 (9839), 411 -423. doi:10.1016/S0140 -
6736(12)60722 -3 
Operario, D., & Nemoto, T. (2010). HIV i n transgender communities: syndemic dynamics and a need for 
multicomponent interventions. J Acquir Immune Defic Syndr, 55 Suppl 2 , S91 -93. 
doi:10.1097/QAI.0b013e3181fbc9ec  
Reisner, S. L., Bailey, Z., & Sevelius, J. (2014). Racial/ethnic disparities in history of incarceration, 
experiences of victimization, and associated health indicators among transgender women in the 
U.S. Women Health, 54 (8), 750 -767. doi:10.1080/03630242. 2014.932891  
Santos, G. M., Wilson, E. C., Rapues, J., Macias, O., Packer, T., & Raymond, H. F. (2014). HIV 
treatment cascade among transgender women in a San Francisco respondent driven sampling 
study. Sex Transm Infect, 90 (5), 430 -433. doi:10.1136/sextran s-2013 -051342  
Sevelius, J. M., Patouhas, E., Keatley, J. G., & Johnson, M. O. (2014). Barriers and facilitators to 
engagement and retention in care among transgender women living with human 
immunodeficiency virus. Ann Behav Med, 47 (1), 5 -16. doi:10.1007/s1 2160 -013-9565 -8 
Sifra Quintana, S., Roshenthan, J., & Krehely, J. (2010). On the Streets: The Federal response to Gay nad 
Transgender Homeless Youth . Retrieved from http://www.americanprogress.org/wp -
content/uploads/issues/2010/06/pdf/lgbtyouthhomelessness.pdf   
Wilson, E. C., Garofalo, R., Harris, R. D., Herrick, A., Martinez, M., Martinez, J., . . . the Adolescent 
Medicine Trials Network for, H. I. V. A. I. (2009). Transgender female youth and sex work: HIV 
risk and a comparison of life factors related to engagement in sex work. AIDS Behav, 13 (5), 902 -
913. doi:10.1007/s10461 -008-9508 -8 
Xavier, J. M., Bobbin, M., Singer, B., & Budd, E. (2005). A ne eds assessment of transgendered people of 
color living in Washington, DC. International Journal of Transgenderism, 8 (2-3), 31 -47.  
  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
Page 39 of 57 
 APPENDIX  I 
Schedule of Evaluations  
Study Component  Pre-Pilot  Pre-
Screenin g T1: Baseline  T2: Immediate Post-
Intervention  T3: 8 Month Follow -Up 
 
Formative Research       
 Focus Group Interview s X     
 Key Informant Interviews  X     
 Community Advisory Board  X X X X X 
 Pre-Test X X X X  
Intervention Pilot Test       
 Time Window     0-2 weeks post-
intervention  ± 4 weeks 8 months post-
intervention  
 Pre-Screening Survey   X    
 Informed Consent    X   
 Eligibility Survey    X   
 ACASI: Socio demographics, 
employment  variables , HIV risk 
behavior, and potential effect 
modifiers   X X  X 
 Biospecimen: HIV/STI screening 
and drug testing    X  X 
 ACASI: Feasibility, acceptability, 
and satisfaction of intervention , 
employment variables , HIV risk 
behavior     X  
 Untoward Events  Assessment  X X X X X 
 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
40 APPENDIX  II 
Phase I Documents  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
41 Focus Group Guide  
Work2Prevent  Focus  Group  Guide  
Hi everyone.  Thanks  for volunteering  to talk with us. My name  is X and this is X. X will be assisting  me 
and taking  notes  during  our group.   
There  are no right  or wrong  answers.  We just want  to hear about  your thoughts  and experience.  You may 
feel the same  or differently  than others  in the group.  This is okay.  If you want  to follow  up on what  
someone  has said, you want  to agree,  disagree,  or give an example,  feel free to do that. You can direct  
your comments  to others  in the group  to respond.  We just ask that only one person  speaks  at a time.   
I am here to ask questions,  listen,  and make  sure everyone  has a chance  to share.  We would  like to hear 
from  all of you so if you’re  talking  a lot, I may ask you to give others  a chance.  If you aren’t  saying  much,  
I might  call on you to share  your ideas.  We will be recording  the session  to make  sure we don’t  miss 
anything  you say, but what  you say will not be linked  to your name  in the course  of our research.   
Also,  we want  to remind  you to please  not share  what  you hear in this group  today.  By nature,  a focus  
group  is neither  private  nor confidential.  However,  it is important  that what  we say here stays  within the 
group.  If you want  to use the bathroom,  please  feel free, we just ask that you get up quietly.  Please  keep  
your cell phones  turned  off until we finish  the session.  We really  appreciate  your full participation.  
Let’s  begin.  To find out a bit more  about each other,  we will go around  the circle.  When  it is your turn, 
please  tell us your first name,  your favorite  city (other  than Chicago),  and where  you’d  like to go on 
vacation  if you could  go anywhere  in the world.  
1. I’d like to start by talking  about  employment  in general.  What  kinds  of jobs have  you had in your 
lifetime?  What  is your favorite  job that you have  had?  What  did you like about  that job? What  is 
your least favorite  job? What  did you not like about  that job? 
2. Let’s  talk about  the job search.  How do you find out about  jobs you might  want  to apply  for? 
[Probe:  internet  – what  sites in particular?,  friends,  family,  etc.] When  looking  online,  what  do 
you search  for? When  you look at a job posting,  what  makes  you decide  to apply?  What  makes  
you decid e not to? 
3. Now  let’s talk about  applying  for a job. What  kinds  of things  have  you had to do to apply  for a 
job? [Probe:  in person  vs. online  application]  Have  you had to provide  a resume?  How  did you 
get your resume  ready?  What  do you include  on your resume ? What  do you leave  off?  
4. Okay,  let’s say you get an interview  for a job. How  do you prepare  for the interview?  What  do 
you wear?  What  time do you show  up? How  does your self-presentation  during  an interview  
differ  from  your self-presentation  on a regular  day?   
5. What  kinds  of experiences  have  you had during  job interviews?  What  questions  have  you been  
asked?  What  was the hardest  question  to answer?  Have  you been  asked  things  that seemed  
inappropriate  (unprofessional)?  Can you give examples?  Have  you ever not gotten  a job because  
of your sexual  orientation  or gender  identity?  How  do you know  that was the reason?   
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
42 6. So let’s say you get hired  for a job (congratulations!).  What  kinds  of challenges  might  a young  
(gay man OR trans  woman)  of color  face when  starting  a new job? When  if ever do you disclose  
your (sexual  orientation  OR gender  identity)?  [Transwomen:  How  do you deal with providing  
paperwork  that might  not match  your gender  presentation?]  
7. Thinking  about  discrimination  at work  now:  Have  you ever had to interact with a 
(homophobic/transphobic)  co-worker  or boss?  What  happened?  How  did you respond?  Were  
there  any people  at that job who supported  you?  Were  there  any policies  against  discrimination?    
8. What  is the longest  you have  ever worked  at the same  place?  What was it about  that job that 
made  you want  to stay?  Did your employer  have  policies  that kept other  co-workers  or 
supervisors  from  discriminating  against  you because  of your sexual  orientation  or gender  
identity?  What  were  those  policies?  How  were  they communicated  to employees?  How  were  they 
enforced?   
9. Thinking  about  positive  work  environments  now:  Have  you ever had a job where  you felt safe 
being  “out”  about  your sexual  orientation/gender  identity?  What  made  that environment  feel safe 
and supportive?  What  could  employers  promote  that kind of supportive  environment?   
Thank  you so much  for your time and input!  We really  appreciate  your participation,  and we value  your 
feedback.   
 
  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
43 Key Informant Employers Guide  
 
Key Informant Interviews: LGBT -inclusive employers  
Thank you for agreeing to participate in this interview.  We are hoping to gather important information in 
order to better understand the experiences of hiring managers in supporting diversity in hiring, 
specifically among LGBT individuals.  We appreciate your time and are very interested in your  point of 
view and opinion.  
We would greatly appreciate it if you could please turn off your cell phone during the session.  
Before we start, I would like to remind you that there are no right or wrong answers to the questions as 
we talk.  We are holding th is interview because we want to learn about your experiences and to hear from 
you.  Any information shared in this session will be confidential. Any information you share will be de -
identified to protect the anonymity of you and your employer. You do not h ave to answer any questions 
you do not wish to answer. If you need to take a break at any point, please let me know.  
1. Please tell me about your position at X company  
a. How long have you worked at X company?  
b. How long have you been in your current position?  
c. What is your role in the hiring process?  
d. How many people have you been involved in hiring?  
 
2. What you typically look for in an employee?  (May need to specify type/level of employee)  
a. Probes: specific skills, disposition/personality, experience, work ethic, d iversity  
b. Can you give me an example of a recent hire? What was the position you were hiring for? 
What were you looking for in that employee? How did you determine that the person you 
hired was the right person for the job?  
  
3. Now thinking a bit more specifically about LGBT people - can you tell me about any protocols or 
policies you have to recruit, hire, and retain individuals who identify as LGBT, that is lesbian, 
gay, bisexual or transgender? (probe: Lesbian, Gay, Bisexual, Transgender)  
 
a. Probe: Are  your policies the same for all of those groups, or are there different policies 
for sexual orientation and gender identity? Can you explain the reasoning behind that? 
How does that work in practice?  
b. Probe: Let’s talk specifically about recruiting employee s here: what policies do you have 
to recruit LGBT employees? How successful have these policies been? What do you 
think could be done to improve these policies?  
c. Probe: What about policies to retain LGBT employees? How successful have these 
policies been? W hat do you think could be done to improve these policies?  
 
4. What are some challenges that someone who is LGB might face working in this field?  
a. What about challenges someone who is LGB might face working at this 
organization/company specifically?  
b. How do th e higher -ups at your company address these challenges?  
c. How do the other staff at your company address these challenges?  
d. Can you give an example of this from your own company?  
 
5. What are some challenges that someone who is transgender might face working in this field?  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
44 a. What about challenges someone who is transgender might face working at this 
organization/company specifically?  
b. How do the higher -ups at your company address these challenges?  
c. How do the other staff at your company address these challenges?  
d. Can you give an example of this from your own company?  
 
6. What are some benefits to the company from having LGBT employees?  
a. Can you give an example of how an LGBT individual has added value to your company?  
 
7. How do your clientele factor into your company’s policies and practices regarding certain sexual 
and gender minorities?  (probe: Lesbian, Gay, Bisexual, Transgender)  
 
8. How might other employees and key stakeholders (board members, shareholders, funders, etc) 
factor into your company’s policies and practic es regarding certain sexual and gender minorities?  
 
9. What barriers to hiring and retaining young transwomen of color in particular have you 
experienced? (Probe: job readiness, interview performance, stereotypes of other employees, self -
presentation, persona lity/disposition, etc.)  
 
10. What barriers to hiring and retaining young gay or bisexual men color in particular have you 
experienced? (Probe: job readiness, interview performance, stereotypes of other employees, self -
presentation, personality/disposition, etc .) 
 
  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
45 Informant YMSM and YTW Guide  
 
Work2Prevent  IDI Guide for MSM/TW  
Hi there,  my name  is _____.  Thanks  for volunteering  to talk with me today.  Before  we get started  on the 
interview,  I’d just like to remind  you of a few things.  First,  there  are no right  or wrong  answers.  I just 
want  to hear about  your thoughts  and experience.  Second,  I’ll be recording  the interview  today  so that I 
can focus  on the interview  instead  of taking  notes.  The recording  will only be used for our research,  and 
your answers  will be confidential,  meaning  that your name  will never  be used in connection  with reports  
from  this study.  Third,  you may skip any question  you do not want  to answer,  and you may end the 
interview  at any time.  If you need  a break  at any point,  just let me know.  Finally,  I ask that you keep  your 
cell phone  on silent  or turned  off until we finish  the interview.  I really  appreciate  your full participation.  
Do you have  any questions  for me at this point?  Feel free to ask at any point  if something  comes  up. 
Okay,  let’s get started!    
1. I’d like to start by talking  about  your employment  history.  Please  walk  me through  all of the jobs 
you’ve  had, starting  with your very first paid employment.   
a. What  was your first job? How  old were  you when  you got it? How  long did you work  there?  
What  kinds  of things  did you do?  
b. What  was your next job? [Repeat  questions  for each job until present  time.]  
c. What  was your favorite  job that you have  had?  What  did you like about  that job? What  was 
your least favorite  job? What  did you not like about  that job? 
2. Now  let’s talk about  the job search.  How  do you find out about  jobs you might  want  to apply  for? 
How  did you find out about  the last job you had?  [Probe:  internet  – what  sites?,  friends,  family,  
etc.]  
a. When  looking  online,  what  do you search  for? When  you look at a job posting,  what  makes  
you decide  to apply?  [Probe:  skills,  experience,  job type,  location,  compensation,  etc.] What  
makes  you decide  not to? 
b. When  you hear about  a job from  family  or friends,  what  sorts  of things  do you ask? [Probe:  
skills,  experience,  job type,  location,  compensation,  etc.] What  makes  you more  likely  to 
apply  for a job that someone  tells you about?  What  makes  you less likely  to apply?   
c. When  you see a help wanted  ad or sign,  how do you decide  whether  to apply  for the job 
advertised?  [Probe:  skills,  experience,  job type,  location,  compensation,  etc.] 
d. Have  you figured  out any ways  to tell if an employer  is LGBT  friendly?  If yes, how did you 
figure  this out? Have  you been  able to apply  this when  looking  for jobs?  If not, are there  
things  that employers  could  do that would  help you know  that they are LGBT  friendly?   
3. Now  let’s talk about  applying  for a job. What  kinds  of things  have  you had to do to apply  for a 
job? [Probe:  in person  vs. online  application]  [Probe:  Think  about  the last job you applied  for…]  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
46 a. Have  you had to provide  a resume?  How  did you get your resume  ready?  What  do you 
include  on your resume?  What  do you leave  off? When  did you first create  a resume?  How  
often  have  you revised  or rewrote  it?  
4. Okay,  let’s say you get an interview  for a job. How  do you prepare  for the interview?   
a. What  do you wear?  How  does your self-presentation  during  an interview  differ  from  your 
self-presentati on on a regular  day?  
b. What  time do you show  up? How  do you act?  
5. Think  specifically  about  the last job you applied  for: did you interview  for that?  What  happened  
during  the interview?  What  questions  did the interviewer  ask?  
a. How  did that interview  compare  to other  job interviews  you’ve  had?  What  kinds  of 
experiences  have  you had during  job interviews?   
b. What  questions  have  you been  asked?  What  was the hardest  question  to answer?  Have  you 
been  asked  things  that seemed  inappropriate  (unprofessional)?  Can you give examples?   
c. Have  you ever not gotten  a job because  of your sexual  orientation  or gender  identity?  What  
made  you think  that was the reason?   
6. So now let’s talk about  what  happens  when  you start a new job. What  kinds  of challenges  have  
you faced  as a young  (gay man OR trans  woman)  of color  when  starting  a new job?  
a. When  (if ever)  have  you disclosed  your (sexual  orientation  OR gender  identity)  to your co-
workers?  What  about  to your boss?   
b. [Transwomen:  How  do you deal with providing  paperwork  that might  not match your gender  
presentation?]  
7. Thinking  about  discrimination  at work  now:  Have  you ever had to interact  with a 
(homophobic/transphobic)  co-worker  or boss?  Can you tell me about  that experience?  
a. What  happened?  How  did you respond?   
b. Were  there  any people  at that job who supported  you?  What  did they do? 
c. Were  there  any policies  against  discrimination  at your job? What  were  those  policies?  How  
were  they enforced,  if at all?  
8. What  is the longest  you have  ever worked  at the same  place?   
a. What  was your job? What  was it about  that job that made  you want  to stay?   
b. Did your employer  have  policies  that kept other  co-workers  or supervisors  from  
discriminating  against  you because  of your sexual  orientation  or gender  identity?  What  were  
those  policies?   
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
47 c. How  were  they communicated  to employees?   
d. How  were  they enforced?   
9. Thinking  about  positive  work  environments  now:  Have  you ever had a job where  you felt safe 
being  “out”  about  your sexual  orientation/gender  identity?   
a. What  made  that environment  feel safe and supportive?   
b. How  could  more  employers  promote  that kind of supportive  environment?   
Thank  you so much  for your time and input!  I really  appreciate  your participation,  and I value  your 
feedback.   
 
 
 
 
 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
48 Screening Instrument  
 

ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
49 APPENDIX  III 
Planned Enrollment Report  – Pilot Test  
This report format should NOT be used for collecting data from study participants.  
Study Title:   Work -to-Prevent: Employment as HIV prevention for young men who have sex 
with men (YMSM) and young transgender women (YTW) [Pilot Test (n=70)]  
Domestic/Foreign:    Domestic   
Comments:  We define male to include anyone who w as assigned male at birth, which would 
include young transgender women (YTW)  
 Ethnic Categories  
Racial Categories  Not Hispanic or Latino  Hispanic or Latino  Total  
 Female  Male  Female  Male   
American Indian / Alaska 
Native  0 0 0 0    0 
Asian  0 0 0 0    0 
Native Hawaiian or Other 
Pacific Islander  0 0 0 0    0 
Black or African American  0 48 0 4   52 
White  0 0 0 12   12 
More Than One Race  0 4 0 2    6 
Total     0   52    0   18   70 
PHS 398 / PHS 2590 (Rev. 08/12 Appr oved Through 8/31/ 2015 )  OMB No.  0925 -0001/ 0002  
 Page 1 Planned Enrollment Report  
 
 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
50 APPENDIX  IV 
iFOUR Description  
Description of the iFOUR Program  
The Increase Individual Income and Independence program (iFOUR) is an employment program that was 
developed over ten years ago to target the employment needs of HIV -positive people. The program was 
based on the Supported Employment framework that was devel oped to help connect people with a range 
of disabilities (physical and cognitive) to employment because of the benefits of employment, both 
monetary and non -monetary. Thus, researchers at the University of Illinois -Chicago collaborated with 
Chicago House, a housing and support organization for HIV -positive individuals, to develop a Supported 
Employment program for HIV -positive individuals. Like Supported Employment, iFOUR provides a 
variety of supports to aid in participants' job success, such as job traini ng referrals, client -tailored job 
placement, post -employment assistance, and benefits planning. The program includes regular interviews 
to evaluate program outcomes, such as medication adherence, use of drugs and alcohol, and assessments 
of physical and me ntal health. Since 2005, the iFOUR program has been refined to better tailor to the 
needs of HIV -positive individuals, including the addition of one -on-one work with a career specialist. 
These specialists assess job readiness and are trained in the impact of HIV/AIDS on employment, so as to 
best assist participants with their career aspirations. They also assist with linking participants to additional 
educational resources and provide support with interview preparation and development of resumes and 
cover l etters. iFOUR also includes a four -week training workshop that is tailored to the needs of HIV -
positive participants, dealing with questions such as workplace discrimination, benefits maintenance, and 
the relationship of health beliefs and work. The worksh op also covers confidence and communication 
skills, while highlighting the non -monetary benefits of employment. The iFOUR program has had 
positive outcomes for participants, documented in several studies (see references below). The goal of the 
current stud y is to tailor and then pilot test the iFOUR program for individuals who are HIV -negative but 
at high -risk for acquiring HIV.    
Related References  
Cook, Judith A.; Razzano , Lisa A.; Swarbrick, Margaret A.; Jonikas, Jessica A.; Yost, Chantelle; Burke, 
Laris a; Steigman, Pamela J.; Santos, Alberto. Health Risks and Changes in Self -Efficacy Following 
Community Health Screening of Adults with Serious Mental Illnesses.  PLoS ONE. Apr2015, Vol. 10 
Issue 4, p1 -15. 15p. DOI: 10.1371/journal.pone.0123552.  
Cook, Judit h A.; Razzano , Lisa A.; Burke -Miller, Jane K.; Blyler, Crystal R.; Leff, H. Stephen; Mueser, 
Kim T.; Gold, Paul B.; Goldberg, Richard W.; Shafer, Michael S.; Onken, Steven J.; McFarlane, William 
R.; Donegan, Kate; Carey, Martha Ann; Kaufmann, Caroline; Gre y, Dennis D. Effects of co -occurring 
disorders on employment outcomes in a multisite randomized study of supported employment for people 
with severe mental illness.  Journal of Rehabilitation Research & Development. 2007, Vol. 44 Issue 6, 
p837 -850. 
Hamilto n, Marie M.; Razzano , Lisa A.; Martin, Nicole B. The Relationship Between Type and Quality of 
Social Support and HIV Medication Adherence. . Journal of HIV/AIDS  & Social Services , 2007, Vol. 6 
Issue 1/2, p39 -63. 
Razzano et al. (2013). The Role of Employmen t in HIV Wellness & Recovery. USCA.  
Razzano , Lisa A.; Hamilton, Marie M.; Yost, Chantelle; Pashka, Nicole J.; Perloff, Judith K. Employment 
Outcomes for Individuals With HIV/AIDS and Co -Occurring Mental Health Factors. American Journal 
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
51 of Psychiatric Rehab ilitation. Jan-Mar2015, Vol. 18 Issue 1, p19 -41. 23p. 4 Charts. DOI: 
10.1080/15487768.2015.1001700  
Razzano , Lisa A.; Hamilton, Marie M.; Perloff, Judith K. Work status, benefits, and financial resources 
among people with HIV/AIDS . Work. 2006, Vol. 27 Issue  3, p235 -245. 
Razzano , Lisa A.; Hamilton, Marie M. Health -related barriers to employment among people with 
HIV/AIDS .  Journal of Vocational Rehabilitation. 2005, Vol. 22 Issue 3, p179 -188.
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
52 APPENDIX  V 
Certificate of Confidentiality   
  
ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
53  

ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
54  

ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
55  
 

ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
56  

ATN 151  
  Version 5.2 
  05/23/2017  
Rev 08/05/2019  
 
57  
